{"PubmedArticleSet": {"PubmedArticle": [{"MedlineCitation": {"@Status": "MEDLINE", "@Owner": "NLM", "PMID": {"@Version": "1", "#text": "30720863"}, "DateCompleted": {"Year": "2020", "Month": "02", "Day": "14"}, "DateRevised": {"Year": "2020", "Month": "02", "Day": "14"}, "Article": {"@PubModel": "Print-Electronic", "Journal": {"ISSN": {"@IssnType": "Electronic", "#text": "1097-0215"}, "JournalIssue": {"@CitedMedium": "Internet", "Volume": "145", "Issue": "6", "PubDate": {"Year": "2019", "Month": "09", "Day": "15"}}, "Title": "International journal of cancer", "ISOAbbreviation": "Int. J. Cancer"}, "ArticleTitle": "Prevalence and clinical outcomes of germline mutations in BRCA1/2 and PALB2 genes in 2769 unselected breast cancer patients in China.", "Pagination": {"MedlinePgn": "1517-1528"}, "ELocationID": {"@EIdType": "doi", "@ValidYN": "Y", "#text": "10.1002/ijc.32184"}, "Abstract": {"AbstractText": "To gain more information on the prevalence of germline mutations in BRCA1/2 and PALB2 genes in the Chinese population, and to explore the effects of the mutation status of these genes on clinical outcomes in patients with breast cancer, we performed a screening for BRCA1/2 and PALB2 mutations in a consecutive series of unselected breast cancer patients in the Chinese population. A total of 2,769 cases were enrolled between June 1993 and September 2017. All of the exons and exon-intron boundaries of the BRCA1/2 and PALB2 genes were screened with next-generation sequencing. Of the 2,769 breast cancer patients, BRCA1, BRCA2 and PALB2 mutations accounted for 2.7% (n\u2009=\u200974), 2.7% (n\u2009=\u200976), and 0.9% (n\u2009=\u200924), respectively. The BRCA1 gene had the highest mutation frequency in patients with triple-negative breast cancer (TNBC), which was 9.6% (n\u2009=\u200942), while the BRCA2 gene had the highest mutation frequency in patients with Luminal, which was 3.2% (n\u2009=\u200958). The disease-free survival (DFS) of BRCA1 mutation carriers was significantly lower than that of noncarriers (adjusted HR\u2009=\u20092.20, 95% CI\u2009=\u20091.15-4.18, p\u2009=\u20090.017). The mutation status of the PALB2 gene was significantly associated with the decline in overall survival (OS) (adjusted HR\u2009=\u20098.38, 95% CI\u2009=\u20092.19-32.11, p\u2009=\u20090.002). No significant difference was found between BRCA2 pathogenic mutation carriers and noncarriers. These results demonstrate that BRCA1 mutation status may be associated with a worse disease progression in patients with breast cancer, and women who harbored a PALB2 mutation might be at a higher risk of death due to breast cancer compared to noncarriers.", "CopyrightInformation": "\u00a9 2019 UICC."}, "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "LastName": "Deng", "ForeName": "Mei", "Initials": "M", "AffiliationInfo": [{"Affiliation": "Department of Surgical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou, China."}, {"Affiliation": "Department of Radiotherapy, Affiliated Hospital, Guilin Medical University, Guilin, Guangxi, China."}]}, {"@ValidYN": "Y", "LastName": "Chen", "ForeName": "Hui-Hui", "Initials": "HH", "AffiliationInfo": [{"Affiliation": "Department of Surgical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou, China."}, {"Affiliation": "The Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Zhejiang, Hangzhou, China."}]}, {"@ValidYN": "Y", "LastName": "Zhu", "ForeName": "Xuan", "Initials": "X", "AffiliationInfo": [{"Affiliation": "Department of Surgical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou, China."}, {"Affiliation": "The Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Zhejiang, Hangzhou, China."}]}, {"@ValidYN": "Y", "LastName": "Luo", "ForeName": "Meng", "Initials": "M", "AffiliationInfo": [{"Affiliation": "Department of Surgical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou, China."}, {"Affiliation": "The Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Zhejiang, Hangzhou, China."}]}, {"@ValidYN": "Y", "LastName": "Zhang", "ForeName": "Kun", "Initials": "K", "AffiliationInfo": [{"Affiliation": "Department of Surgical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou, China."}, {"Affiliation": "The Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Zhejiang, Hangzhou, China."}]}, {"@ValidYN": "Y", "LastName": "Xu", "ForeName": "Chun-Jing", "Initials": "CJ", "AffiliationInfo": [{"Affiliation": "Department of Surgical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou, China."}, {"Affiliation": "The Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Zhejiang, Hangzhou, China."}]}, {"@ValidYN": "Y", "LastName": "Hu", "ForeName": "Kai-Min", "Initials": "KM", "AffiliationInfo": {"Affiliation": "Department of Surgical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou, China."}}, {"@ValidYN": "Y", "LastName": "Cheng", "ForeName": "Pu", "Initials": "P", "AffiliationInfo": {"Affiliation": "Department of Gynecology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China."}}, {"@ValidYN": "Y", "LastName": "Zhou", "ForeName": "Jiao-Jiao", "Initials": "JJ", "AffiliationInfo": [{"Affiliation": "Department of Surgical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou, China."}, {"Affiliation": "The Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Zhejiang, Hangzhou, China."}]}, {"@ValidYN": "Y", "LastName": "Zheng", "ForeName": "Shu", "Initials": "S", "AffiliationInfo": [{"Affiliation": "Department of Surgical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou, China."}, {"Affiliation": "The Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Zhejiang, Hangzhou, China."}]}, {"@ValidYN": "Y", "LastName": "Chen", "ForeName": "Yi-Ding", "Initials": "YD", "Identifier": {"@Source": "ORCID", "#text": "0000-0002-2263-6275"}, "AffiliationInfo": [{"Affiliation": "Department of Surgical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou, China."}, {"Affiliation": "The Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Zhejiang, Hangzhou, China."}]}]}, "Language": "eng", "PublicationTypeList": {"PublicationType": [{"@UI": "D016428", "#text": "Journal Article"}, {"@UI": "D013485", "#text": "Research Support, Non-U.S. Gov't"}]}, "ArticleDate": {"@DateType": "Electronic", "Year": "2019", "Month": "02", "Day": "22"}}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Int J Cancer", "NlmUniqueID": "0042124", "ISSNLinking": "0020-7136"}, "ChemicalList": {"Chemical": [{"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D014408", "#text": "Biomarkers, Tumor"}}, {"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D000076164", "#text": "Fanconi Anemia Complementation Group N Protein"}}, {"RegistryNumber": "0", "NameOfSubstance": {"@UI": "C512790", "#text": "PALB2 protein, human"}}]}, "CitationSubset": "IM", "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"@UI": "D000328", "@MajorTopicYN": "N", "#text": "Adult"}}, {"DescriptorName": {"@UI": "D014408", "@MajorTopicYN": "N", "#text": "Biomarkers, Tumor"}, "QualifierName": {"@UI": "Q000235", "@MajorTopicYN": "Y", "#text": "genetics"}}, {"DescriptorName": {"@UI": "D001943", "@MajorTopicYN": "N", "#text": "Breast Neoplasms"}, "QualifierName": [{"@UI": "Q000235", "@MajorTopicYN": "Y", "#text": "genetics"}, {"@UI": "Q000473", "@MajorTopicYN": "N", "#text": "pathology"}]}, {"DescriptorName": {"@UI": "D018572", "@MajorTopicYN": "N", "#text": "Disease-Free Survival"}}, {"DescriptorName": {"@UI": "D005091", "@MajorTopicYN": "N", "#text": "Exons"}}, {"DescriptorName": {"@UI": "D000076164", "@MajorTopicYN": "N", "#text": "Fanconi Anemia Complementation Group N Protein"}, "QualifierName": {"@UI": "Q000235", "@MajorTopicYN": "Y", "#text": "genetics"}}, {"DescriptorName": {"@UI": "D005260", "@MajorTopicYN": "N", "#text": "Female"}}, {"DescriptorName": {"@UI": "D019398", "@MajorTopicYN": "Y", "#text": "Genes, BRCA1"}}, {"DescriptorName": {"@UI": "D024522", "@MajorTopicYN": "Y", "#text": "Genes, BRCA2"}}, {"DescriptorName": {"@UI": "D006580", "@MajorTopicYN": "N", "#text": "Genetic Carrier Screening"}}, {"DescriptorName": {"@UI": "D018095", "@MajorTopicYN": "Y", "#text": "Germ-Line Mutation"}}, {"DescriptorName": {"@UI": "D006801", "@MajorTopicYN": "N", "#text": "Humans"}}, {"DescriptorName": {"@UI": "D007438", "@MajorTopicYN": "N", "#text": "Introns"}}, {"DescriptorName": {"@UI": "D008875", "@MajorTopicYN": "N", "#text": "Middle Aged"}}, {"DescriptorName": {"@UI": "D015995", "@MajorTopicYN": "N", "#text": "Prevalence"}}]}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"@MajorTopicYN": "Y", "#text": "BRCA1/2"}, {"@MajorTopicYN": "Y", "#text": "PALB2"}, {"@MajorTopicYN": "Y", "#text": "Breast Cancer"}, {"@MajorTopicYN": "Y", "#text": "Germline mutation"}, {"@MajorTopicYN": "Y", "#text": "clinical outcome"}]}}, "PubmedData": {"History": {"PubMedPubDate": [{"@PubStatus": "received", "Year": "2018", "Month": "08", "Day": "17"}, {"@PubStatus": "revised", "Year": "2018", "Month": "12", "Day": "30"}, {"@PubStatus": "accepted", "Year": "2019", "Month": "01", "Day": "22"}, {"@PubStatus": "pubmed", "Year": "2019", "Month": "2", "Day": "6", "Hour": "6", "Minute": "0"}, {"@PubStatus": "medline", "Year": "2020", "Month": "2", "Day": "15", "Hour": "6", "Minute": "0"}, {"@PubStatus": "entrez", "Year": "2019", "Month": "2", "Day": "6", "Hour": "6", "Minute": "0"}]}, "PublicationStatus": "ppublish", "ArticleIdList": {"ArticleId": [{"@IdType": "pubmed", "#text": "30720863"}, {"@IdType": "doi", "#text": "10.1002/ijc.32184"}]}}}, {"MedlineCitation": {"@Status": "MEDLINE", "@Owner": "NLM", "PMID": {"@Version": "1", "#text": "31174498"}, "DateCompleted": {"Year": "2019", "Month": "11", "Day": "20"}, "DateRevised": {"Year": "2020", "Month": "02", "Day": "25"}, "Article": {"@PubModel": "Electronic", "Journal": {"ISSN": {"@IssnType": "Electronic", "#text": "1471-2407"}, "JournalIssue": {"@CitedMedium": "Internet", "Volume": "19", "Issue": "1", "PubDate": {"Year": "2019", "Month": "Jun", "Day": "07"}}, "Title": "BMC cancer", "ISOAbbreviation": "BMC Cancer"}, "ArticleTitle": "Comprehensive mutation detection of BRCA1/2 genes reveals large genomic rearrangements contribute to hereditary breast and ovarian cancer in Chinese women.", "Pagination": {"MedlinePgn": "551"}, "ELocationID": {"@EIdType": "doi", "@ValidYN": "Y", "#text": "10.1186/s12885-019-5765-3"}, "Abstract": {"AbstractText": [{"@Label": "BACKGROUND", "@NlmCategory": "BACKGROUND", "#text": "Mutated BRCA1/2 genes are associated with hereditary breast and ovarian cancer (HBOC). So far most of the identified BRCA1/2 pathogenic variants are single nucleotide variants (SNVs) or insertions/deletions (Indels). However, large genomic rearrangements (LGRs) such as copy number variants (CNVs) are also playing an important role in HBOC predisposition. Their frequency and spectrum have been well studied in western populations but remain largely unknown for Chinese population."}, {"@Label": "METHODS", "@NlmCategory": "METHODS", "#text": "Peripheral blood samples were collected from 218 unrelated familial breast and/or ovarian cancer (FBOC) patients living in Eastern China. PCR-based Sanger sequencing and panel-based next-generation sequencing (NGS) were performed to detect pathogenic SNVs and Indels in BRCA1/2 genes. For the patients lacking small pathogenic variants, multiplex ligation dependent probe amplification (MLPA) assay was conducted to screen for LGRs."}, {"@Label": "RESULTS", "@NlmCategory": "RESULTS", "#text": "In total, we identified 44 samples (20.1%) carrying small pathogenic variants (26 in BRCA1 and 18 in BRCA2, respectively). Among the rest of 174 samples, five were found carrying novel deleterious LGRs in BRCA1 which are exon5-7dup (1 patient), exon13-14dup (2 patients), and exon1-22del (2 patients). No LGR was found in BRCA2. Overall, LGRs accounted for 16.1% (5/31) of BRCA1 pathogenic variants, and were detected in 2.3% (5/218) of all FBOC patients."}, {"@Label": ", CONCLUSIONS", "@NlmCategory": "UNASSIGNED", "#text": "LGR variants in BRCA1 gene play a significant role in Chinese HBOC patients. MLPA or other similar LGR-detecting methods should be recommended along with nucleotide sequencing as the initial screening approach for Chinese HBOC women."}]}, "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "LastName": "Cao", "ForeName": "Wen-Ming", "Initials": "WM", "AffiliationInfo": {"Affiliation": "Department of Medical Oncology, Zhejiang Cancer Hospital, 1 Banshan East Road, Hangzhou, 310022, China."}}, {"@ValidYN": "Y", "LastName": "Zheng", "ForeName": "Ya-Bing", "Initials": "YB", "AffiliationInfo": {"Affiliation": "Department of Medical Oncology, Zhejiang Cancer Hospital, 1 Banshan East Road, Hangzhou, 310022, China."}}, {"@ValidYN": "Y", "LastName": "Gao", "ForeName": "Yun", "Initials": "Y", "AffiliationInfo": {"Affiliation": "Institute of Cancer Research, Zhejiang Cancer Hospital, Hangzhou, 310022, China."}}, {"@ValidYN": "Y", "LastName": "Ding", "ForeName": "Xiao-Wen", "Initials": "XW", "AffiliationInfo": {"Affiliation": "Department of Breast Cancer Surgery, Zhejiang Cancer Hospital, Hangzhou, 310022, China."}}, {"@ValidYN": "Y", "LastName": "Sun", "ForeName": "Yan", "Initials": "Y", "AffiliationInfo": {"Affiliation": "Department of Medical Oncology, Zhejiang Cancer Hospital, 1 Banshan East Road, Hangzhou, 310022, China."}}, {"@ValidYN": "Y", "LastName": "Huang", "ForeName": "Yuan", "Initials": "Y", "AffiliationInfo": {"Affiliation": "Department of Medical Oncology, Zhejiang Cancer Hospital, 1 Banshan East Road, Hangzhou, 310022, China."}}, {"@ValidYN": "Y", "LastName": "Lou", "ForeName": "Cai-Jin", "Initials": "CJ", "AffiliationInfo": {"Affiliation": "Department of Medical Oncology, Zhejiang Cancer Hospital, 1 Banshan East Road, Hangzhou, 310022, China."}}, {"@ValidYN": "Y", "LastName": "Pan", "ForeName": "Zhi-Wen", "Initials": "ZW", "AffiliationInfo": {"Affiliation": "Department of Clinical Laboratory, Zhejiang Cancer Hospital, Hangzhou, 310022, China."}}, {"@ValidYN": "Y", "LastName": "Peng", "ForeName": "Guang", "Initials": "G", "AffiliationInfo": {"Affiliation": "Department of Clinical Cancer Prevention, the University of Texas, MD Anderson Cancer Center, Houston, TX, 77030, USA."}}, {"@ValidYN": "Y", "LastName": "Wang", "ForeName": "Xiao-Jia", "Initials": "XJ", "Identifier": {"@Source": "ORCID", "#text": "http://orcid.org/0000-0002-1084-0535"}, "AffiliationInfo": {"Affiliation": "Department of Medical Oncology, Zhejiang Cancer Hospital, 1 Banshan East Road, Hangzhou, 310022, China. wxiaojia@yahoo.com."}}]}, "Language": "eng", "GrantList": {"@CompleteYN": "Y", "Grant": [{"GrantID": "81672597", "Agency": "National Natural Science Foundation of China", "Country": null}, {"GrantID": "LY17H160038", "Agency": "Natural Science Foundation of Zhejiang Province, China", "Country": null}, {"GrantID": "2012RCB006", "Agency": "Science and Technology Program offered by Health Bureau of Zhejiang Province, China", "Country": null}, {"GrantID": "2014KYA006", "Agency": "Science and Technology Program offered by Health Bureau of Zhejiang Province, China", "Country": null}, {"GrantID": "2017C03013", "Agency": "Key Research-Development Program of Zhejiang Province", "Country": null}, {"GrantID": "2019C04001", "Agency": "Key Research-Development Program of Zhejiang Province", "Country": null}]}, "PublicationTypeList": {"PublicationType": {"@UI": "D016428", "#text": "Journal Article"}}, "ArticleDate": {"@DateType": "Electronic", "Year": "2019", "Month": "06", "Day": "07"}}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Cancer", "NlmUniqueID": "100967800", "ISSNLinking": "1471-2407"}, "CitationSubset": "IM", "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"@UI": "D000483", "@MajorTopicYN": "N", "#text": "Alleles"}}, {"DescriptorName": {"@UI": "D019943", "@MajorTopicYN": "N", "#text": "Amino Acid Substitution"}}, {"DescriptorName": {"@UI": "D002681", "@MajorTopicYN": "N", "@Type": "Geographic", "#text": "China"}}, {"DescriptorName": {"@UI": "D005260", "@MajorTopicYN": "N", "#text": "Female"}}, {"DescriptorName": {"@UI": "D015321", "@MajorTopicYN": "Y", "#text": "Gene Rearrangement"}}, {"DescriptorName": {"@UI": "D019398", "@MajorTopicYN": "Y", "#text": "Genes, BRCA1"}}, {"DescriptorName": {"@UI": "D024522", "@MajorTopicYN": "Y", "#text": "Genes, BRCA2"}}, {"DescriptorName": {"@UI": "D020022", "@MajorTopicYN": "Y", "#text": "Genetic Predisposition to Disease"}}, {"DescriptorName": {"@UI": "D023281", "@MajorTopicYN": "Y", "#text": "Genomics"}, "QualifierName": {"@UI": "Q000379", "@MajorTopicYN": "N", "#text": "methods"}}, {"DescriptorName": {"@UI": "D005838", "@MajorTopicYN": "N", "#text": "Genotype"}}, {"DescriptorName": {"@UI": "D061325", "@MajorTopicYN": "N", "#text": "Hereditary Breast and Ovarian Cancer Syndrome"}, "QualifierName": {"@UI": "Q000235", "@MajorTopicYN": "Y", "#text": "genetics"}}, {"DescriptorName": {"@UI": "D006801", "@MajorTopicYN": "N", "#text": "Humans"}}, {"DescriptorName": {"@UI": "D009154", "@MajorTopicYN": "Y", "#text": "Mutation"}}, {"DescriptorName": {"@UI": "D010375", "@MajorTopicYN": "N", "#text": "Pedigree"}}, {"DescriptorName": {"@UI": "D020641", "@MajorTopicYN": "N", "#text": "Polymorphism, Single Nucleotide"}}, {"DescriptorName": {"@UI": "D017422", "@MajorTopicYN": "N", "#text": "Sequence Analysis, DNA"}}]}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"@MajorTopicYN": "N", "#text": "BRCA1"}, {"@MajorTopicYN": "N", "#text": "BRCA2"}, {"@MajorTopicYN": "N", "#text": "Chinese"}, {"@MajorTopicYN": "N", "#text": "Familial breast cancer"}, {"@MajorTopicYN": "N", "#text": "Familial ovarian cancer"}, {"@MajorTopicYN": "N", "#text": "Rearrangement"}]}}, "PubmedData": {"History": {"PubMedPubDate": [{"@PubStatus": "received", "Year": "2017", "Month": "08", "Day": "11"}, {"@PubStatus": "accepted", "Year": "2019", "Month": "05", "Day": "29"}, {"@PubStatus": "entrez", "Year": "2019", "Month": "6", "Day": "9", "Hour": "6", "Minute": "0"}, {"@PubStatus": "pubmed", "Year": "2019", "Month": "6", "Day": "9", "Hour": "6", "Minute": "0"}, {"@PubStatus": "medline", "Year": "2019", "Month": "11", "Day": "21", "Hour": "6", "Minute": "0"}]}, "PublicationStatus": "epublish", "ArticleIdList": {"ArticleId": [{"@IdType": "pubmed", "#text": "31174498"}, {"@IdType": "doi", "#text": "10.1186/s12885-019-5765-3"}, {"@IdType": "pii", "#text": "10.1186/s12885-019-5765-3"}, {"@IdType": "pmc", "#text": "PMC6555923"}]}, "ReferenceList": {"Reference": [{"Citation": "J Natl Cancer Inst. 1999 May 19;91(10):882-5", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "10340909"}}}, {"Citation": "JAMA. 2006 Mar 22;295(12):1379-88", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "16551709"}}}, {"Citation": "Clin Genet. 2007 Apr;71(4):331-42", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "17470134"}}}, {"Citation": "Cancer Res. 2008 Sep 1;68(17):7006-14", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "18703817"}}}, {"Citation": "Breast Cancer Res Treat. 2010 Sep;123(2):581-5", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "20221693"}}}, {"Citation": "Breast Cancer Res Treat. 2011 Jan;125(2):325-49", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "20232141"}}}, {"Citation": "Breast Cancer Res Treat. 2010 Nov;124(2):579-84", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "20617377"}}}, {"Citation": "Breast Cancer Res Treat. 2011 Oct;129(3):1019-20", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "21597919"}}}, {"Citation": "Genet Mol Biol. 2009 Jul;32(3):437-46", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "21637503"}}}, {"Citation": "Breast Cancer Res Treat. 2012 May;133(1):273-83", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "22434521"}}}, {"Citation": "J Epidemiol. 2013;23(2):75-84", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "23318652"}}}, {"Citation": "Clin Chem Lab Med. 2014 Aug;52(8):1119-27", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "24670361"}}}, {"Citation": "Lancet Oncol. 2014 Jun;15(7):e279-89", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "24872111"}}}, {"Citation": "BMC Cancer. 2014 Sep 01;14:645", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25176351"}}}, {"Citation": "Genet Med. 2015 May;17(5):405-24", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25741868"}}}, {"Citation": "PLoS Genet. 2015 May 06;11(5):e1005228", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25945795"}}}, {"Citation": "Cancer Genet. 2015 Sep;208(9):448-54", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "26271414"}}}, {"Citation": "CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "26808342"}}}, {"Citation": "BMC Cancer. 2016 Feb 06;16:64", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "26852015"}}}, {"Citation": "Int J Cancer. 2017 Jul 1;141(1):129-142", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "28294317"}}}, {"Citation": "Clin Cancer Res. 2017 Oct 15;23(20):6113-6119", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "28724667"}}}, {"Citation": "Int J Cancer. 2019 Jan 15;144(2):281-289", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "29752822"}}}, {"Citation": "Cancer Res. 1997 Mar 1;57(5):828-31", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "9041180"}}}]}}}, {"MedlineCitation": {"@Status": "MEDLINE", "@Owner": "NLM", "PMID": {"@Version": "1", "#text": "30611917"}, "DateCompleted": {"Year": "2019", "Month": "04", "Day": "29"}, "DateRevised": {"Year": "2019", "Month": "04", "Day": "29"}, "Article": {"@PubModel": "Print-Electronic", "Journal": {"ISSN": {"@IssnType": "Electronic", "#text": "1873-135X"}, "JournalIssue": {"@CitedMedium": "Internet", "Volume": "813", "PubDate": {"Year": "2019", "Month": "01"}}, "Title": "Mutation research", "ISOAbbreviation": "Mutat. Res."}, "ArticleTitle": "Targeted sequencing to discover germline variants in the BRCA1 and BRCA2 genes in a Russian population and their association with breast cancer risk.", "Pagination": {"MedlinePgn": "51-57"}, "ELocationID": [{"@EIdType": "pii", "@ValidYN": "Y", "#text": "S0027-5107(18)30153-2"}, {"@EIdType": "doi", "@ValidYN": "Y", "#text": "10.1016/j.mrfmmm.2018.12.005"}], "Abstract": {"AbstractText": "BRCA1 and BRCA2 are tumor suppressor genes involved in the repair of DNA damage and transcriptional regulation of the cell cycle. Alterations in BRCA1/2 lead to production of functionally defective proteins that impair DNA repair. Certain mutant variants of BRCA1/2 are strongly associated with increased risk of breast and ovarian cancers, with emerging data on association with other types of cancer. However, variability of BRCA1/2 in Russian populations remains understudied. In this study, we performed targeted sequencing of BRCA1/2 in 145 breast cancer (BC) patients with a family history of BRCA-associated cancers and 47 age-matched cancer-free control individuals with or without a family history of cancer. Subjects for this study were recruited in the Voronezh region of the Russian Federation. We found that two polymorphic variants, rs1799967 (BRCA1) and rs4987117 (BRCA2), were strongly associated with the risk of BC. Both variants have not been previously reported as associated with risk of breast cancer. Presence of the rs4987117 variant increases risk of breast cancer onset (OR\u2009=\u20092.76, p-value\u2009=\u20090.022). Notably, although variant rs80357906 (5382InsC) has been reported as a risk factor for hereditary BC, it was not significantly associated with breast cancer risk in our population (p\u202f=\u202f0.192). We also found 12 novel polymorphic variants in BRCA1/2 genes (2 in BRCA1 and 10 in BRCA2). However, none of these variants demonstrated association with the disease. Five germline variants were observed at high frequency (mean AF\u2009=\u200967.14%) and therefore can be considered as a common haplotype in the Voronezh region of the Russian Federation. In summary, our study demonstrates that known pathological variants of BRCA1/2 genes may not be reflective of breast cancer risk assessment when applied to the Russian population. Further, more extended population-specific studies are needed to reveal the reliable list of BRCA1/2 polymorphisms associated with risk of breast cancer in the Russian population.", "CopyrightInformation": "Copyright \u00a9 2018 Elsevier B.V. All rights reserved."}, "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "LastName": "Solodskikh", "ForeName": "Sergei A", "Initials": "SA", "AffiliationInfo": {"Affiliation": "Department of Genetics, Cytology and Bioengineering, Voronezh State University, Voronezh, Russian Federation. Electronic address: s.solodskih@gmail.com."}}, {"@ValidYN": "Y", "LastName": "Panevina", "ForeName": "Anna V", "Initials": "AV", "AffiliationInfo": {"Affiliation": "Department of Genetics, Cytology and Bioengineering, Voronezh State University, Voronezh, Russian Federation; Department of Surgery, Voronezh Regional Clinical Oncological Dispensary, Voronezh, Russian Federation."}}, {"@ValidYN": "Y", "LastName": "Gryaznova", "ForeName": "Maria V", "Initials": "MV", "AffiliationInfo": {"Affiliation": "Department of Genetics, Cytology and Bioengineering, Voronezh State University, Voronezh, Russian Federation."}}, {"@ValidYN": "Y", "LastName": "Gureev", "ForeName": "Artem P", "Initials": "AP", "AffiliationInfo": {"Affiliation": "Department of Genetics, Cytology and Bioengineering, Voronezh State University, Voronezh, Russian Federation."}}, {"@ValidYN": "Y", "LastName": "Serzhantova", "ForeName": "Olga V", "Initials": "OV", "AffiliationInfo": {"Affiliation": "Department of Surgery, Voronezh Regional Clinical Oncological Dispensary, Voronezh, Russian Federation."}}, {"@ValidYN": "Y", "LastName": "Mikhailov", "ForeName": "Andrei A", "Initials": "AA", "AffiliationInfo": {"Affiliation": "Department of Surgery, Voronezh Regional Clinical Oncological Dispensary, Voronezh, Russian Federation."}}, {"@ValidYN": "Y", "LastName": "Maslov", "ForeName": "Alexander Y", "Initials": "AY", "AffiliationInfo": {"Affiliation": "Department of Genetics, Cytology and Bioengineering, Voronezh State University, Voronezh, Russian Federation; Department of Genetics, Albert Einstein College of Medicine of Yeshiva University, New-York, USA."}}, {"@ValidYN": "Y", "LastName": "Popov", "ForeName": "Vasily N", "Initials": "VN", "AffiliationInfo": {"Affiliation": "Department of Genetics, Cytology and Bioengineering, Voronezh State University, Voronezh, Russian Federation. Electronic address: pvn@bio.vsu.ru."}}]}, "Language": "eng", "PublicationTypeList": {"PublicationType": [{"@UI": "D016428", "#text": "Journal Article"}, {"@UI": "D013485", "#text": "Research Support, Non-U.S. Gov't"}]}, "ArticleDate": {"@DateType": "Electronic", "Year": "2018", "Month": "12", "Day": "29"}}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Mutat Res", "NlmUniqueID": "0400763", "ISSNLinking": "0027-5107"}, "CitationSubset": "IM", "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"@UI": "D001943", "@MajorTopicYN": "N", "#text": "Breast Neoplasms"}, "QualifierName": {"@UI": "Q000235", "@MajorTopicYN": "Y", "#text": "genetics"}}, {"DescriptorName": {"@UI": "D016022", "@MajorTopicYN": "N", "#text": "Case-Control Studies"}}, {"DescriptorName": {"@UI": "D005260", "@MajorTopicYN": "N", "#text": "Female"}}, {"DescriptorName": {"@UI": "D019398", "@MajorTopicYN": "Y", "#text": "Genes, BRCA1"}}, {"DescriptorName": {"@UI": "D024522", "@MajorTopicYN": "Y", "#text": "Genes, BRCA2"}}, {"DescriptorName": {"@UI": "D020022", "@MajorTopicYN": "Y", "#text": "Genetic Predisposition to Disease"}}, {"DescriptorName": {"@UI": "D005820", "@MajorTopicYN": "N", "#text": "Genetic Testing"}}, {"DescriptorName": {"@UI": "D018095", "@MajorTopicYN": "Y", "#text": "Germ-Line Mutation"}}, {"DescriptorName": {"@UI": "D006801", "@MajorTopicYN": "N", "#text": "Humans"}}, {"DescriptorName": {"@UI": "D012426", "@MajorTopicYN": "N", "@Type": "Geographic", "#text": "Russia"}}]}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"@MajorTopicYN": "Y", "#text": "BRCA1"}, {"@MajorTopicYN": "Y", "#text": "BRCA2"}, {"@MajorTopicYN": "Y", "#text": "Breast cancer"}, {"@MajorTopicYN": "Y", "#text": "Cancer risk"}, {"@MajorTopicYN": "Y", "#text": "Genetic polymorphism"}, {"@MajorTopicYN": "Y", "#text": "Germline mutations"}, {"@MajorTopicYN": "Y", "#text": "Next-generation sequencing"}, {"@MajorTopicYN": "Y", "#text": "Polymorphic variant"}, {"@MajorTopicYN": "Y", "#text": "Targeted sequencing"}]}}, "PubmedData": {"History": {"PubMedPubDate": [{"@PubStatus": "received", "Year": "2018", "Month": "12", "Day": "14"}, {"@PubStatus": "revised", "Year": "2018", "Month": "12", "Day": "27"}, {"@PubStatus": "accepted", "Year": "2018", "Month": "12", "Day": "28"}, {"@PubStatus": "pubmed", "Year": "2019", "Month": "1", "Day": "7", "Hour": "6", "Minute": "0"}, {"@PubStatus": "medline", "Year": "2019", "Month": "4", "Day": "30", "Hour": "6", "Minute": "0"}, {"@PubStatus": "entrez", "Year": "2019", "Month": "1", "Day": "7", "Hour": "6", "Minute": "0"}]}, "PublicationStatus": "ppublish", "ArticleIdList": {"ArticleId": [{"@IdType": "pubmed", "#text": "30611917"}, {"@IdType": "pii", "#text": "S0027-5107(18)30153-2"}, {"@IdType": "doi", "#text": "10.1016/j.mrfmmm.2018.12.005"}]}}}, {"MedlineCitation": {"@Status": "MEDLINE", "@Owner": "NLM", "PMID": {"@Version": "1", "#text": "29777908"}, "DateCompleted": {"Year": "2018", "Month": "06", "Day": "13"}, "DateRevised": {"Year": "2018", "Month": "06", "Day": "13"}, "Article": {"@PubModel": "Print-Electronic", "Journal": {"ISSN": {"@IssnType": "Electronic", "#text": "1879-0038"}, "JournalIssue": {"@CitedMedium": "Internet", "Volume": "668", "PubDate": {"Year": "2018", "Month": "Aug", "Day": "20"}}, "Title": "Gene", "ISOAbbreviation": "Gene"}, "ArticleTitle": "Breast cancer in the GCC countries: A focus on BRCA1/2 and non-BRCA1/2 genes.", "Pagination": {"MedlinePgn": "73-76"}, "ELocationID": [{"@EIdType": "pii", "@ValidYN": "Y", "#text": "S0378-1119(18)30534-1"}, {"@EIdType": "doi", "@ValidYN": "Y", "#text": "10.1016/j.gene.2018.05.045"}], "Abstract": {"AbstractText": "The GCC is an economic alliance of six Arab countries, including Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and United Arab Emirates (UAE). The rate of endogamous marriage among the GCC countries is approaching 100%, with very high consanguineous marriage rates. Although breast cancer is on the rise in the GCC countries, there are dearth of studies reporting on the genetic epidemiology of breast cancer. In this study, we investigated the frequency of BRCA1/2 and non-BRCA1/2 mutations in breast cancer patients in the GCC countries. BRCA1/2 mutations seem not to be significantly involved in hereditary breast cancer in the GCC countries, which is the most reported form of cancer in Oman, however no available data about the BRCA1/2 mutations role in breast cancer in the UAE. Mutations in more than 30 non-BRCA1/2 genes were reported to be associated with breast cancer patients in the GCC countries, some with comparable frequencies to the BRCA1/2 genes. Arab patients with breast cancer showed advanced stages of cancer and younger ages of onset compared to other Western countries. The Arab genome project pioneered by Saudi Arabia, followed by Qatar, Kuwait, and UAE, will help in the identification of new biomarkers for breast cancer that will be a target for new therapeutics and is expected to improve the prognosis of the disease. However, there is an urgent need for extensive well-controlled genetic epidemiological studies to provide accurate estimates of the frequency of genetic variants in both BRCA1/2 and non-BRCA1/2 among patients with breast cancer in the Gulf States, to provide better care and genetic counseling for Arab patients with predisposing genetic mutations to breast cancer.", "CopyrightInformation": "Copyright \u00a9 2018 Elsevier B.V. All rights reserved."}, "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "LastName": "Rahman", "ForeName": "Sumaya", "Initials": "S", "AffiliationInfo": {"Affiliation": "Department of Biomedical Sciences, College of Health and Sciences, Qatar University, Doha, Qatar."}}, {"@ValidYN": "Y", "LastName": "Zayed", "ForeName": "Hatem", "Initials": "H", "AffiliationInfo": {"Affiliation": "Department of Biomedical Sciences, College of Health and Sciences, Qatar University, Doha, Qatar. Electronic address: hatem.zayed@qu.edu.qa."}}]}, "Language": "eng", "PublicationTypeList": {"PublicationType": [{"@UI": "D016428", "#text": "Journal Article"}, {"@UI": "D016454", "#text": "Review"}]}, "ArticleDate": {"@DateType": "Electronic", "Year": "2018", "Month": "05", "Day": "17"}}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Gene", "NlmUniqueID": "7706761", "ISSNLinking": "0378-1119"}, "CitationSubset": "IM", "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"@UI": "D001943", "@MajorTopicYN": "N", "#text": "Breast Neoplasms"}, "QualifierName": {"@UI": "Q000235", "@MajorTopicYN": "Y", "#text": "genetics"}}, {"DescriptorName": {"@UI": "D005260", "@MajorTopicYN": "N", "#text": "Female"}}, {"DescriptorName": {"@UI": "D019398", "@MajorTopicYN": "Y", "#text": "Genes, BRCA1"}}, {"DescriptorName": {"@UI": "D024522", "@MajorTopicYN": "Y", "#text": "Genes, BRCA2"}}, {"DescriptorName": {"@UI": "D023281", "@MajorTopicYN": "N", "#text": "Genomics"}}, {"DescriptorName": {"@UI": "D006801", "@MajorTopicYN": "N", "#text": "Humans"}}, {"DescriptorName": {"@UI": "D007730", "@MajorTopicYN": "N", "#text": "Kuwait"}}, {"DescriptorName": {"@UI": "D008877", "@MajorTopicYN": "N", "#text": "Middle East"}}, {"DescriptorName": {"@UI": "D009154", "@MajorTopicYN": "Y", "#text": "Mutation"}}, {"DescriptorName": {"@UI": "D009850", "@MajorTopicYN": "N", "#text": "Oman"}}, {"DescriptorName": {"@UI": "D011780", "@MajorTopicYN": "N", "#text": "Qatar"}}, {"DescriptorName": {"@UI": "D012529", "@MajorTopicYN": "N", "#text": "Saudi Arabia"}}]}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"@MajorTopicYN": "N", "#text": "BRCA1/2"}, {"@MajorTopicYN": "N", "#text": "Breast cancer"}, {"@MajorTopicYN": "N", "#text": "Clinical molecular diagnostics"}, {"@MajorTopicYN": "N", "#text": "GCC countries"}, {"@MajorTopicYN": "N", "#text": "Genetic variants"}, {"@MajorTopicYN": "N", "#text": "Non-BRCA1/2"}, {"@MajorTopicYN": "N", "#text": "Variant interpretation"}]}}, "PubmedData": {"History": {"PubMedPubDate": [{"@PubStatus": "received", "Year": "2018", "Month": "03", "Day": "18"}, {"@PubStatus": "accepted", "Year": "2018", "Month": "05", "Day": "13"}, {"@PubStatus": "pubmed", "Year": "2018", "Month": "5", "Day": "20", "Hour": "6", "Minute": "0"}, {"@PubStatus": "medline", "Year": "2018", "Month": "6", "Day": "14", "Hour": "6", "Minute": "0"}, {"@PubStatus": "entrez", "Year": "2018", "Month": "5", "Day": "20", "Hour": "6", "Minute": "0"}]}, "PublicationStatus": "ppublish", "ArticleIdList": {"ArticleId": [{"@IdType": "pubmed", "#text": "29777908"}, {"@IdType": "pii", "#text": "S0378-1119(18)30534-1"}, {"@IdType": "doi", "#text": "10.1016/j.gene.2018.05.045"}]}}}, {"MedlineCitation": {"@Status": "MEDLINE", "@Owner": "NLM", "PMID": {"@Version": "1", "#text": "28985766"}, "DateCompleted": {"Year": "2017", "Month": "11", "Day": "07"}, "DateRevised": {"Year": "2020", "Month": "02", "Day": "25"}, "Article": {"@PubModel": "Electronic", "Journal": {"ISSN": {"@IssnType": "Electronic", "#text": "0717-6287"}, "JournalIssue": {"@CitedMedium": "Internet", "Volume": "50", "Issue": "1", "PubDate": {"Year": "2017", "Month": "Oct", "Day": "06"}}, "Title": "Biological research", "ISOAbbreviation": "Biol. Res."}, "ArticleTitle": "Mutations in BRCA1, BRCA2 and other breast and ovarian cancer susceptibility genes in Central and South American populations.", "Pagination": {"MedlinePgn": "35"}, "ELocationID": {"@EIdType": "doi", "@ValidYN": "Y", "#text": "10.1186/s40659-017-0139-2"}, "Abstract": {"AbstractText": "Breast cancer (BC) is the most common malignancy among women worldwide. A major advance in the understanding of the genetic etiology of BC was the discovery of BRCA1 and BRCA2 (BRCA1/2) genes, which are considered high-penetrance BC genes. In non-carriers of BRCA1/2 mutations, disease susceptibility may be explained of a small number of mutations in BRCA1/2 and a much higher proportion of mutations in ethnicity-specific moderate- and/or low-penetrance genes. In Central and South American populations, studied have focused on analyzing the distribution and prevalence of BRCA1/2 mutations and other susceptibility genes that are scarce in Latin America as compared to North America, Europe, Australia, and Israel. Thus, the aim of this review is to present the current state of knowledge regarding pathogenic BRCA variants and other BC susceptibility genes. We conducted a comprehensive review of 47 studies from 12 countries in Central and South America published between 2002 and 2017 reporting the prevalence and/or spectrum of mutations and pathogenic variants in BRCA1/2 and other BC susceptibility genes. The studies on BRCA1/2 mutations screened a total of 5956 individuals, and studies on susceptibility genes analyzed a combined sample size of 11,578 individuals. To date, a total of 190 different BRCA1/2 pathogenic mutations in Central and South American populations have been reported in the literature. Pathogenic mutations or variants that increase BC risk have been reported in the following genes or genomic regions: ATM, BARD1, CHECK2, FGFR2, GSTM1, MAP3K1, MTHFR, PALB2, RAD51, TOX3, TP53, XRCC1, and 2q35."}, "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "LastName": "Jara", "ForeName": "Lilian", "Initials": "L", "AffiliationInfo": [{"Affiliation": "Human Genetics Program, Institute of Biomedical Sciences (ICBM), School of Medicine, University of Chile, Santiago, Chile. ljara@uchile.cl."}, {"Affiliation": "Laboratorio de Gen\u00e9tica Molecular Humana, Facultad de Medicina, Instituto de Ciencias Biom\u00e9dicas (ICBM), Programa de Gen\u00e9tica, Universidad de Chile, Independencia 1027, Santiago, Chile. ljara@uchile.cl."}]}, {"@ValidYN": "Y", "LastName": "Morales", "ForeName": "Sebastian", "Initials": "S", "AffiliationInfo": {"Affiliation": "Human Genetics Program, Institute of Biomedical Sciences (ICBM), School of Medicine, University of Chile, Santiago, Chile."}}, {"@ValidYN": "Y", "LastName": "de Mayo", "ForeName": "Tomas", "Initials": "T", "AffiliationInfo": [{"Affiliation": "Human Genetics Program, Institute of Biomedical Sciences (ICBM), School of Medicine, University of Chile, Santiago, Chile."}, {"Affiliation": "Center for Genetics and Genomics Faculty of Medicine, Clinica Alemana Universidad del desarrollo, Avenida Las Condes, 12438 Lo Barnechea, Santiago, Chile."}, {"Affiliation": "Laboratorio de Gen\u00e9tica Molecular Humana, Facultad de Medicina, Instituto de Ciencias Biom\u00e9dicas (ICBM), Programa de Gen\u00e9tica, Universidad de Chile, Independencia 1027, Santiago, Chile."}]}, {"@ValidYN": "Y", "LastName": "Gonzalez-Hormazabal", "ForeName": "Patricio", "Initials": "P", "AffiliationInfo": {"Affiliation": "Human Genetics Program, Institute of Biomedical Sciences (ICBM), School of Medicine, University of Chile, Santiago, Chile."}}, {"@ValidYN": "Y", "LastName": "Carrasco", "ForeName": "Valentina", "Initials": "V", "AffiliationInfo": {"Affiliation": "Human Genetics Program, Institute of Biomedical Sciences (ICBM), School of Medicine, University of Chile, Santiago, Chile."}}, {"@ValidYN": "Y", "LastName": "Godoy", "ForeName": "Raul", "Initials": "R", "AffiliationInfo": {"Affiliation": "Human Genetics Program, Institute of Biomedical Sciences (ICBM), School of Medicine, University of Chile, Santiago, Chile."}}]}, "Language": "eng", "PublicationTypeList": {"PublicationType": [{"@UI": "D016428", "#text": "Journal Article"}, {"@UI": "D016454", "#text": "Review"}]}, "ArticleDate": {"@DateType": "Electronic", "Year": "2017", "Month": "10", "Day": "06"}}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Biol Res", "NlmUniqueID": "9308271", "ISSNLinking": "0716-9760"}, "CitationSubset": "IM", "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"@UI": "D001943", "@MajorTopicYN": "N", "#text": "Breast Neoplasms"}, "QualifierName": {"@UI": "Q000235", "@MajorTopicYN": "Y", "#text": "genetics"}}, {"DescriptorName": {"@UI": "D002489", "@MajorTopicYN": "N", "#text": "Central America"}}, {"DescriptorName": {"@UI": "D005260", "@MajorTopicYN": "N", "#text": "Female"}}, {"DescriptorName": {"@UI": "D019398", "@MajorTopicYN": "Y", "#text": "Genes, BRCA1"}}, {"DescriptorName": {"@UI": "D024522", "@MajorTopicYN": "Y", "#text": "Genes, BRCA2"}}, {"DescriptorName": {"@UI": "D020022", "@MajorTopicYN": "N", "#text": "Genetic Predisposition to Disease"}, "QualifierName": {"@UI": "Q000235", "@MajorTopicYN": "Y", "#text": "genetics"}}, {"DescriptorName": {"@UI": "D006801", "@MajorTopicYN": "N", "#text": "Humans"}}, {"DescriptorName": {"@UI": "D009154", "@MajorTopicYN": "Y", "#text": "Mutation"}}, {"DescriptorName": {"@UI": "D010051", "@MajorTopicYN": "N", "#text": "Ovarian Neoplasms"}, "QualifierName": {"@UI": "Q000235", "@MajorTopicYN": "Y", "#text": "genetics"}}, {"DescriptorName": {"@UI": "D013020", "@MajorTopicYN": "N", "#text": "South America"}}]}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"@MajorTopicYN": "N", "#text": "Ethnic composition"}, {"@MajorTopicYN": "N", "#text": "Hereditary and early onset breast cancer"}, {"@MajorTopicYN": "N", "#text": "Large genomic rearrangements"}, {"@MajorTopicYN": "N", "#text": "Pathogenic point mutations"}, {"@MajorTopicYN": "N", "#text": "Susceptibility genes"}]}}, "PubmedData": {"History": {"PubMedPubDate": [{"@PubStatus": "received", "Year": "2017", "Month": "08", "Day": "08"}, {"@PubStatus": "accepted", "Year": "2017", "Month": "09", "Day": "20"}, {"@PubStatus": "entrez", "Year": "2017", "Month": "10", "Day": "8", "Hour": "6", "Minute": "0"}, {"@PubStatus": "pubmed", "Year": "2017", "Month": "10", "Day": "8", "Hour": "6", "Minute": "0"}, {"@PubStatus": "medline", "Year": "2017", "Month": "11", "Day": "8", "Hour": "6", "Minute": "0"}]}, "PublicationStatus": "epublish", "ArticleIdList": {"ArticleId": [{"@IdType": "pubmed", "#text": "28985766"}, {"@IdType": "doi", "#text": "10.1186/s40659-017-0139-2"}, {"@IdType": "pii", "#text": "10.1186/s40659-017-0139-2"}, {"@IdType": "pmc", "#text": "PMC6389095"}]}, "ReferenceList": {"Reference": [{"Citation": "Cancer Epidemiol Biomarkers Prev. 1999 Sep;8(9):741-7", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "10498392"}}}, {"Citation": "Br J Cancer. 2000 Nov;83(10):1301-8", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "11044354"}}}, {"Citation": "Nat Med. 2001 May;7(5):552-6", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "11329055"}}}, {"Citation": "Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9330-5", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "11481490"}}}, {"Citation": "Nat Genet. 2002 May;31(1):33-6", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "11984562"}}}, {"Citation": "Hum Mutat. 2002 Dec;20(6):474-5", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "12442275"}}}, {"Citation": "Ann Hum Genet. 2003 Jan;67(Pt 1):71-80", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "12556237"}}}, {"Citation": "Am J Hum Genet. 2003 May;72(5):1117-30", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "12677558"}}}, {"Citation": "N Engl J Med. 2003 Jun 5;348(23):2339-47", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "12788999"}}}, {"Citation": "Biofactors. 2003;17(1-4):115-30", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "12897434"}}}, {"Citation": "Nat Rev Cancer. 2004 Sep;4(9):665-76", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "15343273"}}}, {"Citation": "Cancer Sci. 2004 Nov;95(11):908-13", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "15546509"}}}, {"Citation": "Mutat Res. 2005 Jan 6;569(1-2):123-32", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "15603757"}}}, {"Citation": "Mutat Res. 2005 May;589(3):192-207", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "15878142"}}}, {"Citation": "Salud Publica Mex. 2005 Mar-Apr;47(2):110-5", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "15889636"}}}, {"Citation": "Lancet. 2005 May 21-27;365(9473):1747-9", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "15910935"}}}, {"Citation": "Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8537-42", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "15937124"}}}, {"Citation": "Fam Cancer. 2005;4(2):97-103", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "15951959"}}}, {"Citation": "Breast Cancer Res Treat. 2006 Jan;95(1):81-7", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "16261400"}}}, {"Citation": "Sao Paulo Med J. 2005 Jul 7;123(4):192-7", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "16389418"}}}, {"Citation": "Breast J. 2006 Jan-Feb;12 Suppl 1:S70-80", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "16430400"}}}, {"Citation": "J Clin Oncol. 2006 Feb 20;24(6):863-71", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "16484695"}}}, {"Citation": "Cancer Lett. 2007 Jan 8;245(1-2):96-102", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "16494995"}}}, {"Citation": "Genes Chromosomes Cancer. 2006 Jul;45(7):646-55", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "16575876"}}}, {"Citation": "Mol Cell. 2006 Jun 23;22(6):719-29", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "16793542"}}}, {"Citation": "J Med Genet. 2007 Jan;44(1):1-9", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "16825431"}}}, {"Citation": "J Med Genet. 2006 Nov;43(11):856-62", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "16825437"}}}, {"Citation": "Breast Cancer Res Treat. 2007 Jul;103(3):349-53", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "17063270"}}}, {"Citation": "Breast Cancer Res Treat. 2007 Jun;103(2):225-32", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "17080309"}}}, {"Citation": "Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):654-8", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "17255289"}}}, {"Citation": "Nat Genet. 2007 Mar;39(3):352-8", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "17293864"}}}, {"Citation": "Crit Rev Oncol Hematol. 2007 Aug;63(2):125-49", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "17498966"}}}, {"Citation": "Nature. 2007 Jun 28;447(7148):1087-93", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "17529967"}}}, {"Citation": "Breast Cancer Res Treat. 2008 Aug;110(3):543-5", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "17876702"}}}, {"Citation": "Cancer Genet Cytogenet. 2007 Oct 1;178(1):65-9", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "17889711"}}}, {"Citation": "Nat Genet. 2008 Jan;40(1):17-22", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "18163131"}}}, {"Citation": "JAMA. 2008 Jan 9;299(2):194-201", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "18182601"}}}, {"Citation": "Cancer Lett. 2008 Mar 8;261(1):21-5", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "18248785"}}}, {"Citation": "Br J Cancer. 2008 Apr 22;98(8):1457-66", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "18349832"}}}, {"Citation": "BMC Cancer. 2008 Apr 23;8:117", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "18433505"}}}, {"Citation": "Nat Genet. 2008 Jun;40(6):703-6", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "18438407"}}}, {"Citation": "Clin Cancer Res. 2008 May 1;14(9):2861-9", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "18451254"}}}, {"Citation": "BMC Cancer. 2008 May 30;8:155", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "18513387"}}}, {"Citation": "Am J Hum Genet. 2009 Feb;84(2):115-22", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "19147119"}}}, {"Citation": "Curr Biol. 2009 Mar 24;19(6):524-9", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "19268590"}}}, {"Citation": "Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7155-60", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "19369211"}}}, {"Citation": "Braz J Med Biol Res. 2009 May;42(5):453-7", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "19377795"}}}, {"Citation": "J Biol Chem. 2009 Jul 3;284(27):18302-10", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "19423707"}}}, {"Citation": "Maturitas. 2008 Sep-Oct;61(1-2):141-50", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "19434886"}}}, {"Citation": "CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "19474385"}}}, {"Citation": "Mol Cancer Res. 2009 Jul;7(7):1110-8", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "19584259"}}}, {"Citation": "Nat Rev Cancer. 2009 Oct;9(10):749-58", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "19776744"}}}, {"Citation": "Gynecol Oncol. 2010 May;117(2):211-5", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "19959210"}}}, {"Citation": "Food Chem Toxicol. 2010 Jul;48(7):1881-5", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "20417243"}}}, {"Citation": "Lancet. 2010 Jul 24;376(9737):235-44", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "20609467"}}}, {"Citation": "J Int Med Res. 2010 May-Jun;38(3):977-86", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "20819434"}}}, {"Citation": "Breast Cancer Res Treat. 2011 Apr;126(3):705-16", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "20859677"}}}, {"Citation": "PLoS One. 2010 Oct 13;5(10):e13336", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "20967209"}}}, {"Citation": "Breast Cancer Res Treat. 2011 Jul;128(1):211-8", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "21190077"}}}, {"Citation": "Cancer. 2011 May 15;117(10):2228-35", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "21192060"}}}, {"Citation": "Breast Cancer Res Treat. 2011 Aug;128(3):845-53", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "21327469"}}}, {"Citation": "Clin Genet. 2012 Nov;82(5):484-8", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "21895635"}}}, {"Citation": "Gynecol Oncol. 2012 Feb;124(2):236-43", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "22044689"}}}, {"Citation": "Hered Cancer Clin Pract. 2011 Dec 20;9:12", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "22185575"}}}, {"Citation": "Mol Biol Rep. 2012 Aug;39(8):8091-8", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "22544576"}}}, {"Citation": "PLoS One. 2012;7(5):e37432", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "22655046"}}}, {"Citation": "Biol Res. 2012;45(2):117-30", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "23096355"}}}, {"Citation": "Breast Cancer Res Treat. 2013 Jan;137(2):559-69", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "23225170"}}}, {"Citation": "PLoS One. 2013;8(3):e57581", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "23469205"}}}, {"Citation": "Hum Genet. 2013 Aug;132(8):845-63", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "23552954"}}}, {"Citation": "J Clin Oncol. 2013 Jul 10;31(20):2619-26", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "23733769"}}}, {"Citation": "Arch Med Res. 2013 Aug;44(6):459-66", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "24054997"}}}, {"Citation": "Springerplus. 2013 Sep 11;2:450", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "24083102"}}}, {"Citation": "J Med Genet. 2014 Feb;51(2):98-107", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "24285858"}}}, {"Citation": "Rev Bras Ginecol Obstet. 2013 Dec;35(12):569-74", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "24500512"}}}, {"Citation": "Mol Biol Rep. 2014 Jun;41(6):3715-22", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "24532140"}}}, {"Citation": "Hered Cancer Clin Pract. 2014 Apr 17;12(1):11", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "24742220"}}}, {"Citation": "Genet Mol Biol. 2014 Mar;37(1 Suppl):151-70", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "24764751"}}}, {"Citation": "BMC Med Genet. 2014 May 15;15:55", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "24884479"}}}, {"Citation": "Science. 2014 Jun 13;344(6189):1280-5", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "24926019"}}}, {"Citation": "PLoS One. 2014 Jun 17;9(6):e99893", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "24936644"}}}, {"Citation": "Salud Publica Mex. 2014 Apr;56(2):206-12", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25014427"}}}, {"Citation": "Proc Natl Acad Sci U S A. 2014 Sep 30;111(39):14205-10", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25192939"}}}, {"Citation": "Tumour Biol. 2014 Dec;35(12):11895-901", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25217320"}}}, {"Citation": "Cancer. 2015 Feb 1;121(3):372-8", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25236687"}}}, {"Citation": "Clin Genet. 2015 Oct;88(4):371-5", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25256238"}}}, {"Citation": "Cancer Epidemiol Biomarkers Prev. 2015 Mar;24(3):498-505", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25371446"}}}, {"Citation": "Am J Cancer Res. 2014 Dec 15;5(1):466-71", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25628955"}}}, {"Citation": "BMC Cancer. 2015 Jan 31;15:30", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25636233"}}}, {"Citation": "Fam Cancer. 2015 Sep;14(3):349-54", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25690738"}}}, {"Citation": "Tumour Biol. 2015 Aug;36(8):6451-61", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25801246"}}}, {"Citation": "J Natl Cancer Inst. 2015 Apr 08;107(5):null", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25855707"}}}, {"Citation": "Genet Mol Res. 2015 Jun 11;14(2):6465-71", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "26125851"}}}, {"Citation": "Genet Mol Res. 2015 Oct 26;14(4):13066-75", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "26535619"}}}, {"Citation": "PLoS Genet. 2015 Dec 04;11(12):e1005602", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "26636962"}}}, {"Citation": "Hum Genome Var. 2014 Oct 16;1:14012", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "27081505"}}}, {"Citation": "Breast Cancer Res Treat. 2016 Apr;156(3):507-515", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "27083178"}}}, {"Citation": "Genet Mol Res. 2016 May 09;15(2):", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "27173331"}}}, {"Citation": "Genet Mol Biol. 2016 May 24;39(2):199-202", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "27223487"}}}, {"Citation": "Genet Mol Biol. 2016 Apr-Jun;39(2):223-31", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "27303907"}}}, {"Citation": "Oncotarget. 2016 Jul 24;8(36):60487-60495", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "28947987"}}}, {"Citation": "Science. 1994 Oct 7;266(5182):66-71", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "7545954"}}}, {"Citation": "Science. 1994 Sep 30;265(5181):2088-90", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "8091231"}}}, {"Citation": "Nat Genet. 1996 Mar;12(3):333-7", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "8589730"}}}, {"Citation": "Cancer. 1996 Jun 1;77(11):2318-24", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "8635102"}}}, {"Citation": "J Biol Chem. 1997 Dec 19;272(51):31941-4", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "9405383"}}}, {"Citation": "Am J Hum Genet. 1998 Mar;62(3):676-89", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "9497246"}}}]}}}, {"MedlineCitation": {"@Status": "MEDLINE", "@Owner": "NLM", "PMID": {"@Version": "1", "#text": "27658390"}, "DateCompleted": {"Year": "2018", "Month": "03", "Day": "29"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"@PubModel": "Print-Electronic", "Journal": {"ISSN": {"@IssnType": "Electronic", "#text": "2005-9256"}, "JournalIssue": {"@CitedMedium": "Internet", "Volume": "49", "Issue": "3", "PubDate": {"Year": "2017", "Month": "Jul"}}, "Title": "Cancer research and treatment : official journal of Korean Cancer Association", "ISOAbbreviation": "Cancer Res Treat"}, "ArticleTitle": {"i": ["BRCA1", "BRCA2"], "#text": "Clinically Significant Unclassified Variants in  and  genes among Korean Breast Cancer Patients."}, "Pagination": {"MedlinePgn": "627-634"}, "ELocationID": {"@EIdType": "doi", "@ValidYN": "Y", "#text": "10.4143/crt.2016.292"}, "Abstract": {"AbstractText": [{"@Label": "PURPOSE", "@NlmCategory": "OBJECTIVE", "i": ["BRCA1", "BRCA2"], "#text": "Unclassified variants (UVs) of  and  genes are not defined as pathogenic for breast cancer, and their clinical significance currently remains undefined. Therefore, this study was conducted to identify potentially pathogenic UVs by comparing their prevalence between breast cancer patients and controls."}, {"@Label": "MATERIALS AND METHODS", "@NlmCategory": "METHODS", "i": ["BRCA1/2", "BRCA", "in silico"], "#text": "A total of 328 breast cancer patients underwent  genetic screening at the National Cancer Center of Korea. Genetic variants of  genes that were categorized as unclassified according to the Breast Cancer Information Core database were selected based on allelic frequency, after which candidate variants were genotyped in 421 healthy controls. We also examined family members of the study participants. Finally, the effects of amino acid substitutions on protein structure and function were predicted ."}, {"@Label": "RESULTS", "@NlmCategory": "RESULTS", "i": ["BRCA1", "BRCA2", "BRCA1"], "#text": "Genetic tests revealed 33 UVs in  and 47 in . Among 15 candidates genotyped in healthy controls, c.5339T>C in BRCA1 and c.6029T>G, c.7522G>A in BRCA2 were not detected. Moreover, the c.5339T>C variant in the  gene was detected in four patients with a family history of breast cancer. This nonsynonymous variant (Leu1780Pro) in the BRCA1 C-terminal domain was predicted to have an effect on BRCA1 protein structure/function."}, {"@Label": "CONCLUSION", "@NlmCategory": "CONCLUSIONS", "i": ["BRCA", "BRCA1"], "#text": "This study showed that comparison of genotype frequency between cases and controls could help identify UVs of  genes that are potentially pathogenic. Moreover, ourfindings suggest that c.5339T>C in  might be a pathogenic variant for patients and their families."}]}, "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "LastName": "Yoon", "ForeName": "Kyong-Ah", "Initials": "KA", "AffiliationInfo": [{"Affiliation": "Center for Breast Cancer, Hospital, National Cancer Center, Goyang, Korea."}, {"Affiliation": "College of Veterinary Medicine, Konkuk University, Seoul, Korea."}]}, {"@ValidYN": "Y", "LastName": "Park", "ForeName": "Boyoung", "Initials": "B", "AffiliationInfo": {"Affiliation": "Department of Cancer Control and Policy, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea."}}, {"@ValidYN": "Y", "LastName": "Lee", "ForeName": "Byung Il", "Initials": "BI", "AffiliationInfo": {"Affiliation": "Biomolecular Function Research Branch, National Cancer Center, Goyang, Korea."}}, {"@ValidYN": "Y", "LastName": "Yang", "ForeName": "Moon Jung", "Initials": "MJ", "AffiliationInfo": {"Affiliation": "Center for Breast Cancer, Hospital, National Cancer Center, Goyang, Korea."}}, {"@ValidYN": "Y", "LastName": "Kong", "ForeName": "Sun-Young", "Initials": "SY", "AffiliationInfo": [{"Affiliation": "Genetic Counseling Clinic, Hospital, National Cancer Center, Goyang, Korea."}, {"Affiliation": "Department of System Cancer Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea."}, {"Affiliation": "Translational Epidemiology Branch, National Cancer Center, Goyang, Korea."}]}, {"@ValidYN": "Y", "LastName": "Lee", "ForeName": "Eun Sook", "Initials": "ES", "AffiliationInfo": [{"Affiliation": "Center for Breast Cancer, Hospital, National Cancer Center, Goyang, Korea."}, {"Affiliation": "Department of System Cancer Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea."}, {"Affiliation": "Precision Medicine Branch, Research Institute, National Cancer Center, Goyang, Korea."}]}]}, "Language": "eng", "PublicationTypeList": {"PublicationType": {"@UI": "D016428", "#text": "Journal Article"}}, "ArticleDate": {"@DateType": "Electronic", "Year": "2016", "Month": "09", "Day": "13"}}, "MedlineJournalInfo": {"Country": "Korea (South)", "MedlineTA": "Cancer Res Treat", "NlmUniqueID": "101155137", "ISSNLinking": "1598-2998"}, "CitationSubset": "IM", "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"@UI": "D000328", "@MajorTopicYN": "N", "#text": "Adult"}}, {"DescriptorName": {"@UI": "D000368", "@MajorTopicYN": "N", "#text": "Aged"}}, {"DescriptorName": {"@UI": "D000483", "@MajorTopicYN": "N", "#text": "Alleles"}}, {"DescriptorName": {"@UI": "D019943", "@MajorTopicYN": "N", "#text": "Amino Acid Substitution"}}, {"DescriptorName": {"@UI": "D001943", "@MajorTopicYN": "N", "#text": "Breast Neoplasms"}, "QualifierName": [{"@UI": "Q000175", "@MajorTopicYN": "Y", "#text": "diagnosis"}, {"@UI": "Q000453", "@MajorTopicYN": "N", "#text": "epidemiology"}, {"@UI": "Q000235", "@MajorTopicYN": "Y", "#text": "genetics"}]}, {"DescriptorName": {"@UI": "D016022", "@MajorTopicYN": "N", "#text": "Case-Control Studies"}}, {"DescriptorName": {"@UI": "D005260", "@MajorTopicYN": "N", "#text": "Female"}}, {"DescriptorName": {"@UI": "D005787", "@MajorTopicYN": "N", "#text": "Gene Frequency"}}, {"DescriptorName": {"@UI": "D019398", "@MajorTopicYN": "Y", "#text": "Genes, BRCA1"}}, {"DescriptorName": {"@UI": "D024522", "@MajorTopicYN": "Y", "#text": "Genes, BRCA2"}}, {"DescriptorName": {"@UI": "D020022", "@MajorTopicYN": "N", "#text": "Genetic Predisposition to Disease"}}, {"DescriptorName": {"@UI": "D005820", "@MajorTopicYN": "N", "#text": "Genetic Testing"}}, {"DescriptorName": {"@UI": "D014644", "@MajorTopicYN": "Y", "#text": "Genetic Variation"}}, {"DescriptorName": {"@UI": "D005838", "@MajorTopicYN": "N", "#text": "Genotype"}}, {"DescriptorName": {"@UI": "D006801", "@MajorTopicYN": "N", "#text": "Humans"}}, {"DescriptorName": {"@UI": "D008403", "@MajorTopicYN": "N", "#text": "Mass Screening"}}, {"DescriptorName": {"@UI": "D008875", "@MajorTopicYN": "N", "#text": "Middle Aged"}}, {"DescriptorName": {"@UI": "D009154", "@MajorTopicYN": "N", "#text": "Mutation"}}, {"DescriptorName": {"@UI": "D009367", "@MajorTopicYN": "N", "#text": "Neoplasm Staging"}}, {"DescriptorName": {"@UI": "D010375", "@MajorTopicYN": "N", "#text": "Pedigree"}}, {"DescriptorName": {"@UI": "D056910", "@MajorTopicYN": "N", "#text": "Republic of Korea"}, "QualifierName": {"@UI": "Q000453", "@MajorTopicYN": "N", "#text": "epidemiology"}}, {"DescriptorName": {"@UI": "D012306", "@MajorTopicYN": "N", "#text": "Risk"}}, {"DescriptorName": {"@UI": "D014178", "@MajorTopicYN": "N", "#text": "Translocation, Genetic"}}]}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"@MajorTopicYN": "N", "#text": "BRCA1"}, {"@MajorTopicYN": "N", "#text": "BRCA2"}, {"@MajorTopicYN": "N", "#text": "Familial breast cancer"}, {"@MajorTopicYN": "N", "#text": "Unclassified variants"}]}}, "PubmedData": {"History": {"PubMedPubDate": [{"@PubStatus": "received", "Year": "2016", "Month": "07", "Day": "05"}, {"@PubStatus": "accepted", "Year": "2016", "Month": "09", "Day": "13"}, {"@PubStatus": "pubmed", "Year": "2016", "Month": "9", "Day": "24", "Hour": "6", "Minute": "0"}, {"@PubStatus": "medline", "Year": "2018", "Month": "3", "Day": "30", "Hour": "6", "Minute": "0"}, {"@PubStatus": "entrez", "Year": "2016", "Month": "9", "Day": "24", "Hour": "6", "Minute": "0"}]}, "PublicationStatus": "ppublish", "ArticleIdList": {"ArticleId": [{"@IdType": "pubmed", "#text": "27658390"}, {"@IdType": "pii", "#text": "crt.2016.292"}, {"@IdType": "doi", "#text": "10.4143/crt.2016.292"}, {"@IdType": "pmc", "#text": "PMC5512368"}]}, "ReferenceList": {"Reference": [{"Citation": "Genet Test Mol Biomarkers. 2010 Aug;14(4):533-7", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "20642364"}}}, {"Citation": "Curr Protoc Hum Genet. 2016 Apr 01;89:8.16.1-8.16.23", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "27037489"}}}, {"Citation": "Nucleic Acids Res. 2014 Jan;42(Database issue):D980-5", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "24234437"}}}, {"Citation": "J Clin Oncol. 2008 Nov 20;26(33):5393-400", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "18824701"}}}, {"Citation": "Cancer Res Treat. 2015 Apr;47(2):127-41", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25761484"}}}, {"Citation": "Curr Protoc Hum Genet. 2013 Jan;Chapter 7:Unit7.20", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "23315928"}}}, {"Citation": "Cancer Epidemiol Biomarkers Prev. 2014 Apr;23(4):622-8", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "24470074"}}}, {"Citation": "Nucleic Acids Res. 2014 Jul;42(Web Server issue):W252-8", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "24782522"}}}, {"Citation": "Science. 1994 Oct 7;266(5182):120-2", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "7939630"}}}, {"Citation": "Science. 1994 Oct 7;266(5182):66-71", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "7545954"}}}, {"Citation": "Fam Cancer. 2006;5(1):89-93", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "16528612"}}}, {"Citation": "Biochemistry. 2011 May 31;50(21):4579-89", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "21473589"}}}, {"Citation": "Nat Methods. 2010 Apr;7(4):248-9", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "20354512"}}}, {"Citation": "Nature. 1995 Dec 21-28;378(6559):789-92", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "8524414"}}}, {"Citation": "Structure. 2010 Feb 10;18(2):167-76", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "20159462"}}}, {"Citation": "Breast Cancer Res. 2009;11(1):R8", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "19200354"}}}, {"Citation": "Nucleic Acids Res. 2012 Jul;40(Web Server issue):W452-7", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "22689647"}}}, {"Citation": "Breast Cancer Res Treat. 2015 May;151(1):157-68", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25863477"}}}, {"Citation": "Breast Cancer Res Treat. 2012 Jun;133(3):1143-52", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "22382806"}}}, {"Citation": "Cancers (Basel). 2010 Sep 10;2(3):1644-60", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "24281179"}}}, {"Citation": "Hum Mutat. 2000;16(2):123-31", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "10923033"}}}, {"Citation": "Am J Hum Genet. 2007 Nov;81(5):873-83", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "17924331"}}}]}}}, {"MedlineCitation": {"@Status": "MEDLINE", "@Owner": "NLM", "PMID": {"@Version": "1", "#text": "28971451"}, "DateCompleted": {"Year": "2018", "Month": "04", "Day": "26"}, "DateRevised": {"Year": "2018", "Month": "04", "Day": "26"}, "Article": {"@PubModel": "Print", "Journal": {"ISSN": {"@IssnType": "Print", "#text": "0065-2598"}, "JournalIssue": {"@CitedMedium": "Print", "Volume": "987", "PubDate": {"Year": "2017"}}, "Title": "Advances in experimental medicine and biology", "ISOAbbreviation": "Adv. Exp. Med. Biol."}, "ArticleTitle": "Biobibliometrics (UGDH-TP53-BRCA1) Genes Connections in the Possible Relationship Between Breast Cancer and EEG.", "Pagination": {"MedlinePgn": "99-107"}, "ELocationID": {"@EIdType": "doi", "@ValidYN": "Y", "#text": "10.1007/978-3-319-57379-3_10"}, "Abstract": {"AbstractText": "In recent years there has been an increasingly amount of data stored in biomedical Databases due to the breakthroughs in biology and bioinformatics, biomedical information is growing exponentially making efficient information retrieval from scientist more and more challenging. New Scientific fields as Bioinformatics seem to be the tool needed to extract scientifically important data based on experimental results and information provided by papers and journals. In this paper we are going to implement a custom made IT system in order to find connections between genes in the breast cancer pathways such the BRCA1 with the electrical energy in the human brain with UGDH gene via the TP53 tumor gene. The proposed system will be able to identify the appearance of each gene ID and compare the coexistence of two genes in PubMed articles/papers. The final system could become a useful tool against the struggle of scientists and medical professionals in the near future."}, "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "LastName": "Martzoukos", "ForeName": "Yannis", "Initials": "Y", "AffiliationInfo": {"Affiliation": "Faculty of Information Science and Informatics, Ionian University, Corfu, Greece."}}, {"@ValidYN": "Y", "LastName": "Papavlasopoulos", "ForeName": "Sozon", "Initials": "S", "AffiliationInfo": {"Affiliation": "Faculty of Information Science and Informatics, Ionian University, Corfu, Greece."}}, {"@ValidYN": "Y", "LastName": "Poulos", "ForeName": "Marios", "Initials": "M", "AffiliationInfo": {"Affiliation": "Faculty of Information Science and Informatics, Ionian University, Corfu, Greece. mpoulos@ionio.gr."}}, {"@ValidYN": "Y", "LastName": "Syrrou", "ForeName": "Maria", "Initials": "M", "AffiliationInfo": {"Affiliation": "Medical School of Ioannina, University of Ioannina, Ioannina, Greece."}}]}, "Language": "eng", "PublicationTypeList": {"PublicationType": {"@UI": "D016428", "#text": "Journal Article"}}}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Adv Exp Med Biol", "NlmUniqueID": "0121103", "ISSNLinking": "0065-2598"}, "ChemicalList": {"Chemical": [{"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D019313", "#text": "BRCA1 Protein"}}, {"RegistryNumber": "0", "NameOfSubstance": {"@UI": "C492913", "#text": "BRCA1 protein, human"}}, {"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D016159", "#text": "Tumor Suppressor Protein p53"}}, {"RegistryNumber": "EC 1.1.1.22", "NameOfSubstance": {"@UI": "D014533", "#text": "Uridine Diphosphate Glucose Dehydrogenase"}}]}, "CitationSubset": "IM", "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"@UI": "D019313", "@MajorTopicYN": "N", "#text": "BRCA1 Protein"}, "QualifierName": {"@UI": "Q000235", "@MajorTopicYN": "Y", "#text": "genetics"}}, {"DescriptorName": {"@UI": "D015706", "@MajorTopicYN": "Y", "#text": "Bibliometrics"}}, {"DescriptorName": {"@UI": "D001921", "@MajorTopicYN": "N", "#text": "Brain"}, "QualifierName": [{"@UI": "Q000378", "@MajorTopicYN": "N", "#text": "metabolism"}, {"@UI": "Q000503", "@MajorTopicYN": "N", "#text": "physiopathology"}]}, {"DescriptorName": {"@UI": "D001943", "@MajorTopicYN": "N", "#text": "Breast Neoplasms"}, "QualifierName": [{"@UI": "Q000175", "@MajorTopicYN": "Y", "#text": "diagnosis"}, {"@UI": "Q000235", "@MajorTopicYN": "N", "#text": "genetics"}, {"@UI": "Q000503", "@MajorTopicYN": "N", "#text": "physiopathology"}]}, {"DescriptorName": {"@UI": "D004569", "@MajorTopicYN": "Y", "#text": "Electroencephalography"}}, {"DescriptorName": {"@UI": "D005260", "@MajorTopicYN": "N", "#text": "Female"}}, {"DescriptorName": {"@UI": "D006801", "@MajorTopicYN": "N", "#text": "Humans"}}, {"DescriptorName": {"@UI": "D016247", "@MajorTopicYN": "N", "#text": "Information Storage and Retrieval"}, "QualifierName": [{"@UI": "Q000379", "@MajorTopicYN": "N", "#text": "methods"}, {"@UI": "Q000706", "@MajorTopicYN": "N", "#text": "statistics & numerical data"}]}, {"DescriptorName": {"@UI": "D011379", "@MajorTopicYN": "N", "#text": "Prognosis"}}, {"DescriptorName": {"@UI": "D015398", "@MajorTopicYN": "N", "#text": "Signal Transduction"}, "QualifierName": {"@UI": "Q000235", "@MajorTopicYN": "N", "#text": "genetics"}}, {"DescriptorName": {"@UI": "D016159", "@MajorTopicYN": "N", "#text": "Tumor Suppressor Protein p53"}, "QualifierName": {"@UI": "Q000235", "@MajorTopicYN": "Y", "#text": "genetics"}}, {"DescriptorName": {"@UI": "D014533", "@MajorTopicYN": "N", "#text": "Uridine Diphosphate Glucose Dehydrogenase"}, "QualifierName": {"@UI": "Q000235", "@MajorTopicYN": "Y", "#text": "genetics"}}]}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"@MajorTopicYN": "Y", "#text": "Bibliometrics"}, {"@MajorTopicYN": "Y", "#text": "Bioinformatics"}, {"@MajorTopicYN": "Y", "#text": "Co-citation coupling"}, {"@MajorTopicYN": "Y", "#text": "Gene"}, {"@MajorTopicYN": "Y", "#text": "MedLine"}, {"@MajorTopicYN": "Y", "#text": "PubMed"}, {"@MajorTopicYN": "Y", "#text": "Unattended system"}]}}, "PubmedData": {"History": {"PubMedPubDate": [{"@PubStatus": "entrez", "Year": "2017", "Month": "10", "Day": "4", "Hour": "6", "Minute": "0"}, {"@PubStatus": "pubmed", "Year": "2017", "Month": "10", "Day": "4", "Hour": "6", "Minute": "0"}, {"@PubStatus": "medline", "Year": "2018", "Month": "4", "Day": "27", "Hour": "6", "Minute": "0"}]}, "PublicationStatus": "ppublish", "ArticleIdList": {"ArticleId": [{"@IdType": "pubmed", "#text": "28971451"}, {"@IdType": "doi", "#text": "10.1007/978-3-319-57379-3_10"}]}}}, {"MedlineCitation": {"@Status": "MEDLINE", "@Owner": "NLM", "PMID": {"@Version": "1", "#text": "31481248"}, "DateCompleted": {"Year": "2019", "Month": "12", "Day": "02"}, "DateRevised": {"Year": "2019", "Month": "12", "Day": "02"}, "Article": {"@PubModel": "Print-Electronic", "Journal": {"ISSN": {"@IssnType": "Electronic", "#text": "1095-6859"}, "JournalIssue": {"@CitedMedium": "Internet", "Volume": "155", "Issue": "2", "PubDate": {"Year": "2019", "Month": "11"}}, "Title": "Gynecologic oncology", "ISOAbbreviation": "Gynecol. Oncol."}, "ArticleTitle": "Using next-generation sequencing (NGS) platform to diagnose pathogenic germline BRCA1/2 mutations from archival tumor specimens.", "Pagination": {"MedlinePgn": "275-279"}, "ELocationID": [{"@EIdType": "pii", "@ValidYN": "Y", "#text": "S0090-8258(19)31479-9"}, {"@EIdType": "doi", "@ValidYN": "Y", "#text": "10.1016/j.ygyno.2019.08.027"}], "Abstract": {"AbstractText": [{"@Label": "OBJECTIVE", "#text": "Clinical genetic testing to diagnose germline mutations often requires blood sample or saliva smear from a cancer-affected individual. This rules out testing in families when cancer-affected individuals are deceased. We explored the use of a next-generation sequencing (NGS) platform to diagnose germline pathogenic mutations from tumors."}, {"@Label": "METHODS", "#text": "Archival tumors (ovarian\u202f=\u202f26, breast\u202f=\u202f25, others\u202f=\u202f9) were retrieved from 60 cancer patients who have undergone multi-gene panel blood testing. Genomic DNA was extracted and sequenced for BRCA1/2 using a NGS platform. 41/60 specimens were sequenced for 5 other genes (APC, ATM, PALB2, PTEN, TP53). Tumor testing and results interpretation were performed blinded to the blood test result."}, {"@Label": "RESULTS", "#text": "All 38 patients with no BRCA1/2 mutations on blood testing were correctly tested negative on tumor. Tumor testing correctly diagnosed BRCA1/2 pathogenic mutations in 15/22 (68%) patients while in 7/22 (32%) patients, the mutation was either detected but incorrectly classified as VUS (n\u202f=\u202f3) or not detected at all (n\u202f=\u202f4). Overall concordance rate for tumor and blood testing for BRCA1/2 mutations was 88%, with 0% false positive and 32% false negative rate for pathogenic mutations. Tumor testing correctly diagnosed 1/2 pathogenic germline ATM mutation, 1/1 pathogenic germline PALB2 mutation and 2/2 pathogenic germline TP53 mutations. False positive germline mutations were diagnosed in 4 genes at a rate of 2.4%-10.3% (APC\u202f=\u202f2.4%, PALB2\u202f=\u202f2.4%, PTEN\u202f=\u202f4.9%, TP53\u202f=\u202f10.3%)."}, {"@Label": "CONCLUSION", "#text": "Tumor testing for BRCA1/2 germline mutations using an NGS platform is fairly reliable with no false positive findings, and correctly diagnosed more than two-thirds of pathogenic germline BRCA1/2 mutations. However, it is not reliable to diagnose pathogenic germline mutations in genes frequently mutated in sporadic cancers, such as PTEN and TP53."}], "CopyrightInformation": "Copyright \u00a9 2019 Elsevier Inc. All rights reserved."}, "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "LastName": "Ong", "ForeName": "Pei Yi", "Initials": "PY", "AffiliationInfo": {"Affiliation": "Department of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS), Singapore."}}, {"@ValidYN": "Y", "LastName": "Poon", "ForeName": "Song Ling", "Initials": "SL", "AffiliationInfo": {"Affiliation": "ACT Genomics Co., Ltd."}}, {"@ValidYN": "Y", "LastName": "Tan", "ForeName": "Kien Thiam", "Initials": "KT", "AffiliationInfo": {"Affiliation": "ACT Genomics Co., Ltd."}}, {"@ValidYN": "Y", "LastName": "Putti", "ForeName": "Thomas Choudary", "Initials": "TC", "AffiliationInfo": {"Affiliation": "Department of Pathology, National University Hospital, Singapore, Singapore."}}, {"@ValidYN": "Y", "LastName": "Ow", "ForeName": "Samuel Guan Wei", "Initials": "SGW", "AffiliationInfo": {"Affiliation": "Department of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS), Singapore."}}, {"@ValidYN": "Y", "LastName": "Chen", "ForeName": "Shu-Jen", "Initials": "SJ", "AffiliationInfo": {"Affiliation": "ACT Genomics Co., Ltd."}}, {"@ValidYN": "Y", "LastName": "Chen", "ForeName": "Chien-Hong", "Initials": "CH", "AffiliationInfo": {"Affiliation": "ACT Genomics Co., Ltd."}}, {"@ValidYN": "Y", "LastName": "Lee", "ForeName": "Soo-Chin", "Initials": "SC", "AffiliationInfo": {"Affiliation": "Department of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS), Singapore; Cancer Science Institute, Singapore, Singapore. Electronic address: csilsc@nus.edu.sg."}}]}, "Language": "eng", "PublicationTypeList": {"PublicationType": [{"@UI": "D016428", "#text": "Journal Article"}, {"@UI": "D013485", "#text": "Research Support, Non-U.S. Gov't"}]}, "ArticleDate": {"@DateType": "Electronic", "Year": "2019", "Month": "08", "Day": "31"}}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Gynecol Oncol", "NlmUniqueID": "0365304", "ISSNLinking": "0090-8258"}, "ChemicalList": {"Chemical": [{"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D004273", "#text": "DNA, Neoplasm"}}, {"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D016159", "#text": "Tumor Suppressor Protein p53"}}]}, "CitationSubset": "IM", "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"@UI": "D000328", "@MajorTopicYN": "N", "#text": "Adult"}}, {"DescriptorName": {"@UI": "D000368", "@MajorTopicYN": "N", "#text": "Aged"}}, {"DescriptorName": {"@UI": "D001943", "@MajorTopicYN": "N", "#text": "Breast Neoplasms"}, "QualifierName": [{"@UI": "Q000175", "@MajorTopicYN": "N", "#text": "diagnosis"}, {"@UI": "Q000235", "@MajorTopicYN": "Y", "#text": "genetics"}]}, {"DescriptorName": {"@UI": "D004273", "@MajorTopicYN": "N", "#text": "DNA, Neoplasm"}, "QualifierName": {"@UI": "Q000235", "@MajorTopicYN": "N", "#text": "genetics"}}, {"DescriptorName": {"@UI": "D005189", "@MajorTopicYN": "N", "#text": "False Positive Reactions"}}, {"DescriptorName": {"@UI": "D005260", "@MajorTopicYN": "N", "#text": "Female"}}, {"DescriptorName": {"@UI": "D019398", "@MajorTopicYN": "N", "#text": "Genes, BRCA1"}, "QualifierName": {"@UI": "Q000502", "@MajorTopicYN": "Y", "#text": "physiology"}}, {"DescriptorName": {"@UI": "D024522", "@MajorTopicYN": "N", "#text": "Genes, BRCA2"}, "QualifierName": {"@UI": "Q000502", "@MajorTopicYN": "Y", "#text": "physiology"}}, {"DescriptorName": {"@UI": "D018095", "@MajorTopicYN": "N", "#text": "Germ-Line Mutation"}, "QualifierName": {"@UI": "Q000235", "@MajorTopicYN": "Y", "#text": "genetics"}}, {"DescriptorName": {"@UI": "D006801", "@MajorTopicYN": "N", "#text": "Humans"}}, {"DescriptorName": {"@UI": "D008875", "@MajorTopicYN": "N", "#text": "Middle Aged"}}, {"DescriptorName": {"@UI": "D010051", "@MajorTopicYN": "N", "#text": "Ovarian Neoplasms"}, "QualifierName": [{"@UI": "Q000175", "@MajorTopicYN": "N", "#text": "diagnosis"}, {"@UI": "Q000235", "@MajorTopicYN": "Y", "#text": "genetics"}]}, {"DescriptorName": {"@UI": "D011446", "@MajorTopicYN": "N", "#text": "Prospective Studies"}}, {"DescriptorName": {"@UI": "D017422", "@MajorTopicYN": "N", "#text": "Sequence Analysis, DNA"}}, {"DescriptorName": {"@UI": "D016159", "@MajorTopicYN": "N", "#text": "Tumor Suppressor Protein p53"}, "QualifierName": {"@UI": "Q000378", "@MajorTopicYN": "N", "#text": "metabolism"}}]}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"@MajorTopicYN": "Y", "#text": "Archival tumor"}, {"@MajorTopicYN": "Y", "#text": "BRCA1/2"}, {"@MajorTopicYN": "Y", "#text": "Genetic testing"}, {"@MajorTopicYN": "Y", "#text": "Germline mutations"}, {"@MajorTopicYN": "Y", "#text": "Next-generation sequencing"}]}}, "PubmedData": {"History": {"PubMedPubDate": [{"@PubStatus": "received", "Year": "2019", "Month": "01", "Day": "19"}, {"@PubStatus": "revised", "Year": "2019", "Month": "08", "Day": "17"}, {"@PubStatus": "accepted", "Year": "2019", "Month": "08", "Day": "23"}, {"@PubStatus": "pubmed", "Year": "2019", "Month": "9", "Day": "5", "Hour": "6", "Minute": "0"}, {"@PubStatus": "medline", "Year": "2019", "Month": "12", "Day": "4", "Hour": "6", "Minute": "0"}, {"@PubStatus": "entrez", "Year": "2019", "Month": "9", "Day": "5", "Hour": "6", "Minute": "0"}]}, "PublicationStatus": "ppublish", "ArticleIdList": {"ArticleId": [{"@IdType": "pubmed", "#text": "31481248"}, {"@IdType": "pii", "#text": "S0090-8258(19)31479-9"}, {"@IdType": "doi", "#text": "10.1016/j.ygyno.2019.08.027"}]}}}, {"MedlineCitation": {"@Status": "MEDLINE", "@IndexingMethod": "Curated", "@Owner": "NLM", "PMID": {"@Version": "1", "#text": "28190311"}, "DateCompleted": {"Year": "2017", "Month": "06", "Day": "05"}, "DateRevised": {"Year": "2018", "Month": "12", "Day": "02"}, "Article": {"@PubModel": "Print", "Journal": {"ISSN": {"@IssnType": "Print", "#text": "0529-567X"}, "JournalIssue": {"@CitedMedium": "Print", "Volume": "52", "Issue": "1", "PubDate": {"Year": "2017", "Month": "Jan", "Day": "25"}}, "Title": "Zhonghua fu chan ke za zhi", "ISOAbbreviation": "Zhonghua Fu Chan Ke Za Zhi"}, "ArticleTitle": "[Clinical-based study of ovarian cancer patients with and without BRCA1/2 genes mutation: clinical features and pedigree analysis].", "Pagination": {"MedlinePgn": "20-25"}, "ELocationID": {"@EIdType": "doi", "@ValidYN": "Y", "#text": "10.3760/cma.j.issn.0529-567X.2017.01.006"}, "Abstract": {"AbstractText": {"b": ["Objective:", "Methods:", "Results:", "Conclusions:"], "i": ["P=", "P=", "P>"], "#text": "To compare the clinical and histological features and prognosis of patients with ovarian cancer from different genetic background, and to make further understanding of the genetic model of BRCA genes used pedigree analysis.  There were 71 patients from 67 independent families enrolled in our study from Apr. 2000 to Jun. 2009 in Peking Union Medical College Hospital. All exons of BRCA1/2 genes were analyzed using denaturing high-performance liquid chromatography(DHPLC) followed by direct sequencing, and clinical features of patients were compared by statistical analysis. Pedigree analysis of two families with BRCA genes mutation were performed.  The mutation rate of BRCA genes was 28% (20/71). The frequency of BRCA1 and BRCA2 gene mutation was 23% (16/71) and 6% (4/71), respectively (0.004). Histology types of patients with and without BRCA genes mutation were different. The onset age between patients with and without BRCA genes mutation was similar (52.6 versus 54.6 years old, 0.393), and tend to be early-onset breast or ovarian cancer in high-risk group. There was no significant difference of platinum-resistant rate, disease free survival and overall survival rate between patients with and without BRCA genes mutation (all 0.05). According to the pedigree analysis, up to 100% of female offspring inherited pathogenic mutations, and male offspring could be a mutation carrier.  The genetic screening and clinical intervention should be performed as early as possible for the members from families at risk of hereditary ovarian cancer. Genetic consulting is important for patients with high-grade papillary serous adenocarcinoma of ovary. It is still unknown that whether the patients with BRCA gene mutations have better prognosis than sporadic ones, and further perspective, randomized controlled trial is still needed."}}, "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "LastName": "Tao", "ForeName": "T", "Initials": "T", "AffiliationInfo": {"Affiliation": "Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China."}}, {"@ValidYN": "Y", "LastName": "Yang", "ForeName": "J X", "Initials": "JX"}, {"@ValidYN": "Y", "LastName": "Shen", "ForeName": "K", "Initials": "K"}, {"@ValidYN": "Y", "LastName": "Cao", "ForeName": "D Y", "Initials": "DY"}]}, "Language": "chi", "PublicationTypeList": {"PublicationType": {"@UI": "D016428", "#text": "Journal Article"}}}, "MedlineJournalInfo": {"Country": "China", "MedlineTA": "Zhonghua Fu Chan Ke Za Zhi", "NlmUniqueID": "16210370R", "ISSNLinking": "0529-567X"}, "ChemicalList": {"Chemical": [{"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D019313", "#text": "BRCA1 Protein"}}, {"RegistryNumber": "0", "NameOfSubstance": {"@UI": "C492913", "#text": "BRCA1 protein, human"}}]}, "CitationSubset": "IM", "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"@UI": "D000328", "@MajorTopicYN": "N", "#text": "Adult"}}, {"DescriptorName": {"@UI": "D019313", "@MajorTopicYN": "N", "#text": "BRCA1 Protein"}, "QualifierName": {"@UI": "Q000235", "@MajorTopicYN": "Y", "#text": "genetics"}}, {"DescriptorName": {"@UI": "D001943", "@MajorTopicYN": "N", "#text": "Breast Neoplasms"}, "QualifierName": {"@UI": "Q000235", "@MajorTopicYN": "N", "#text": "genetics"}}, {"DescriptorName": {"@UI": "D005091", "@MajorTopicYN": "N", "#text": "Exons"}}, {"DescriptorName": {"@UI": "D005260", "@MajorTopicYN": "N", "#text": "Female"}}, {"DescriptorName": {"@UI": "D019398", "@MajorTopicYN": "Y", "#text": "Genes, BRCA1"}}, {"DescriptorName": {"@UI": "D024522", "@MajorTopicYN": "Y", "#text": "Genes, BRCA2"}}, {"DescriptorName": {"@UI": "D005820", "@MajorTopicYN": "N", "#text": "Genetic Testing"}}, {"DescriptorName": {"@UI": "D006801", "@MajorTopicYN": "N", "#text": "Humans"}}, {"DescriptorName": {"@UI": "D008297", "@MajorTopicYN": "N", "#text": "Male"}}, {"DescriptorName": {"@UI": "D008875", "@MajorTopicYN": "N", "#text": "Middle Aged"}}, {"DescriptorName": {"@UI": "D009154", "@MajorTopicYN": "N", "#text": "Mutation"}, "QualifierName": {"@UI": "Q000235", "@MajorTopicYN": "Y", "#text": "genetics"}}, {"DescriptorName": {"@UI": "D010051", "@MajorTopicYN": "N", "#text": "Ovarian Neoplasms"}, "QualifierName": {"@UI": "Q000235", "@MajorTopicYN": "Y", "#text": "genetics"}}, {"DescriptorName": {"@UI": "D010375", "@MajorTopicYN": "N", "#text": "Pedigree"}}, {"DescriptorName": {"@UI": "D011379", "@MajorTopicYN": "N", "#text": "Prognosis"}}]}, "OtherAbstract": {"@Type": "Publisher", "@Language": "chi", "AbstractText": {"b": ["\u76ee\u7684\uff1a", "\u65b9\u6cd5\uff1a", "\u7ed3\u679c\uff1a", "\u7ed3\u8bba\uff1a"], "i": ["P=", "P=", "P>"], "#text": "\u6bd4\u8f83\u4e0d\u540c\u9057\u4f20\u80cc\u666f\u5375\u5de2\u4e0a\u76ae\u6027\u764c\uff08\u5375\u5de2\u764c\uff09\u60a3\u8005\u7684\u4e34\u5e8a\u7279\u70b9\u3001\u75c5\u7406\u5b66\u7279\u5f81\u53ca\u9884\u540e\uff0c\u901a\u8fc7\u5bb6\u7cfb\u5206\u6790\uff0c\u8fdb\u4e00\u6b65\u4e86\u89e3BRCA\u57fa\u56e0\u7a81\u53d8\u7684\u9057\u4f20\u6a21\u5f0f\u3002 \u9009\u53d62000\u5e744\u6708\u81f32009\u5e746\u6708\u95f4\u5c31\u8bca\u4e8e\u5317\u4eac\u534f\u548c\u533b\u9662\u7684\u5375\u5de2\u764c\u60a3\u8005\uff0c\u5171\u5165\u900971\u4f8b\u5375\u5de2\u764c\u60a3\u8005\uff0c\u91c7\u7528\u53d8\u6027\u9ad8\u538b\u6db2\u76f8\u8272\u8c31\uff08DHPLC\uff09\u8054\u5408DNA\u6d4b\u5e8f\u7684\u65b9\u6cd5\u5bf9\u6240\u6709\u60a3\u8005\u5916\u5468\u8840BRCA1\u548cBRCA2\u57fa\u56e0\u8fdb\u884c\u5168\u5e8f\u5217\u68c0\u6d4b\u3002\u5206\u522b\u5bf9\u643a\u5e26\u548c\u672a\u643a\u5e26BRCA\u57fa\u56e0\u7a81\u53d8\u7684\u60a3\u8005\u5206\u6790\u5176\u4e34\u5e8a\u7279\u70b9\u3001\u75c5\u7406\u7c7b\u578b\u53ca\u9884\u540e\u3002\u9009\u53d62\u4e2a\u643a\u5e26BRCA\u57fa\u56e0\u7a81\u53d8\u7684\u5bb6\u65cf\uff0c\u5bf9\u5176\u5168\u90e8\u5973\u6027\u6210\u5458\u8fdb\u884cBRCA1\u548cBRCA2\u57fa\u56e0\u68c0\u6d4b\uff0c\u5e76\u8fdb\u884c\u5bb6\u7cfb\u5206\u6790\u3002  71\u4f8b\u5375\u5de2\u764c\u60a3\u8005BRCA\u57fa\u56e0\u603b\u7a81\u53d8\u7387\u4e3a28%\uff0820/71\uff09\uff0c\u5176\u4e2dBRCA1\u548cBRCA2\u57fa\u56e0\u7684\u7a81\u53d8\u7387\u5206\u522b\u4e3a23%\uff0816/71\uff09\u548c6%\uff084/71\uff09\uff0c\u4e24\u8005\u6bd4\u8f83\uff0c\u5dee\u5f02\u6709\u7edf\u8ba1\u5b66\u610f\u4e49\uff080.004\uff09\u3002\u643a\u5e26\u548c\u672a\u643a\u5e26BRCA\u57fa\u56e0\u7a81\u53d8\u7684\u60a3\u8005\u75c5\u7406\u7c7b\u578b\u7684\u6784\u6210\u6709\u5dee\u5f02\uff0c\u643a\u5e26\u800595%\uff0819/20\uff09\u4e3a\u5375\u5de2\u6d46\u6db2\u6027\u817a\u764c\uff0c85%\uff0817/20\uff09\u4e3a\u9ad8\u7ea7\u522b\u3002\u53d1\u75c5\u5e74\u9f84\u5728\u643a\u5e26\u4e0e\u672a\u643a\u5e26\u8005\u95f4\u867d\u65e0\u660e\u663e\u5dee\u5f02\uff08\u4e2d\u4f4d\u53d1\u75c5\u5e74\u9f84\u5206\u522b\u4e3a52.6\u300154.6\u5c81\uff0c0.393\uff09\uff0c\u4f46\u9ad8\u5371\u5bb6\u65cf\u4e2d\u7b2c2\u4ee3\u7684\u80bf\u7624\u53d1\u75c5\u5e74\u9f84\u6709\u65e9\u4e8e\u7b2c1\u4ee3\u7684\u8d8b\u52bf\uff0c\u4e14\u5375\u5de2\u764c\u548c\u4e73\u817a\u764c\u5747\u6709\u65e9\u53d1\u8d8b\u52bf\u3002\u643a\u5e26\u548c\u672a\u643a\u5e26BRCA\u57fa\u56e0\u7a81\u53d8\u7684\u60a3\u8005\u94c2\u7c7b\u8010\u836f\u6bd4\u4f8b\u3001\u65e0\u7624\u751f\u5b58\u671f\u548c\u603b\u751f\u5b58\u7387\u5206\u522b\u6bd4\u8f83\uff0c\u5dee\u5f02\u5747\u65e0\u7edf\u8ba1\u5b66\u610f\u4e49\uff080.05\uff09\u3002\u5bb6\u7cfb\u5206\u6790\u663e\u793a\uff0c\u5973\u6027\u5b50\u4ee3\u5bf9\u4e8eBRCA\u57fa\u56e0\u81f4\u75c5\u6027\u7a81\u53d8\u7684\u7ee7\u627f\u7387\u5f88\u9ad8\uff0c\u751a\u81f3\u53ef\u4ee5\u9ad8\u8fbe100%\uff1b\u7537\u6027\u6210\u5458\u53ef\u4ee5\u4f5c\u4e3a\u7a81\u53d8\u643a\u5e26\u8005\uff0c\u4e14\u6d88\u5316\u9053\u80bf\u7624\u9ad8\u53d1\u3002 \u91cd\u89c6\u5bb6\u65cf\u53f2\u548c\u4e2a\u4eba\u53f2\u5bf9\u80bf\u7624\u7684\u9884\u6d4b\u4f5c\u7528\uff0c\u5c3d\u65e9\u8fdb\u884c\u5375\u5de2\u764c\u7684\u9057\u4f20\u54a8\u8be2\u548c\u7b5b\u67e5\u5de5\u4f5c\uff1b\u5bf9\u4e8e\u9ad8\u7ea7\u522b\u6d46\u6db2\u6027\u5375\u5de2\u764c\u60a3\u8005\u5e94\u91cd\u89c6\u5176\u9057\u4f20\u80cc\u666f\u7684\u54a8\u8be2\u3002BRCA\u57fa\u56e0\u7a81\u53d8\u76f8\u5173\u7684\u5375\u5de2\u764c\u60a3\u8005\u7684\u5316\u7597\u654f\u611f\u6027\u548c\u9884\u540e\u662f\u5426\u4f18\u4e8e\u6563\u53d1\u6027\u60a3\u8005\uff0c\u4ecd\u9700\u8981\u57fa\u4e8e\u4e0d\u540c\u9057\u4f20\u80cc\u666f\u7684\u5927\u578b\u968f\u673a\u5bf9\u7167\u7814\u7a76\u52a0\u4ee5\u8bc1\u5b9e\u3002."}}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"@MajorTopicYN": "Y", "#text": "Gene detection"}, {"@MajorTopicYN": "Y", "#text": "Genes, BRCA1"}, {"@MajorTopicYN": "Y", "#text": "Genes, BRCA2"}, {"@MajorTopicYN": "Y", "#text": "Mutation"}, {"@MajorTopicYN": "Y", "#text": "Ovarian neoplasms"}]}}, "PubmedData": {"History": {"PubMedPubDate": [{"@PubStatus": "entrez", "Year": "2017", "Month": "2", "Day": "13", "Hour": "6", "Minute": "0"}, {"@PubStatus": "pubmed", "Year": "2017", "Month": "2", "Day": "14", "Hour": "6", "Minute": "0"}, {"@PubStatus": "medline", "Year": "2017", "Month": "6", "Day": "6", "Hour": "6", "Minute": "0"}]}, "PublicationStatus": "ppublish", "ArticleIdList": {"ArticleId": [{"@IdType": "pubmed", "#text": "28190311"}, {"@IdType": "doi", "#text": "10.3760/cma.j.issn.0529-567X.2017.01.006"}]}}}, {"MedlineCitation": {"@Status": "MEDLINE", "@Owner": "NLM", "PMID": {"@Version": "1", "#text": "29053726"}, "DateCompleted": {"Year": "2017", "Month": "11", "Day": "21"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"@PubModel": "Electronic-eCollection", "Journal": {"ISSN": {"@IssnType": "Electronic", "#text": "1932-6203"}, "JournalIssue": {"@CitedMedium": "Internet", "Volume": "12", "Issue": "10", "PubDate": {"Year": "2017"}}, "Title": "PloS one", "ISOAbbreviation": "PLoS ONE"}, "ArticleTitle": "Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1).", "Pagination": {"MedlinePgn": "e0186043"}, "ELocationID": {"@EIdType": "doi", "@ValidYN": "Y", "#text": "10.1371/journal.pone.0186043"}, "Abstract": {"AbstractText": [{"@Label": "BACKGROUND", "@NlmCategory": "BACKGROUND", "#text": "Identification of families at risk for ovarian cancer offers the opportunity to consider prophylactic surgery thus reducing ovarian cancer mortality. So far, identification of potentially affected families in Germany was solely performed via family history and numbers of affected family members with breast or ovarian cancer. However, neither the prevalence of deleterious variants in BRCA1/2 in ovarian cancer in Germany nor the reliability of family history as trigger for genetic counselling has ever been evaluated."}, {"@Label": "METHODS", "@NlmCategory": "METHODS", "#text": "Prospective counseling and germline testing of consecutive patients with primary diagnosis or with platinum-sensitive relapse of an invasive epithelial ovarian cancer. Testing included 25 candidate and established risk genes. Among these 25 genes, 16 genes (ATM, BRCA1, BRCA2, CDH1, CHEK2, MLH1, MSH2, MSH6, NBN, PMS2, PTEN, PALB2, RAD51C, RAD51D, STK11, TP53) were defined as established cancer risk genes. A positive family history was defined as at least one relative with breast cancer or ovarian cancer or breast cancer in personal history."}, {"@Label": "RESULTS", "@NlmCategory": "RESULTS", "#text": "In total, we analyzed 523 patients: 281 patients with primary diagnosis of ovarian cancer and 242 patients with relapsed disease. Median age at primary diagnosis was 58 years (range 16-93) and 406 patients (77.6%) had a high-grade serous ovarian cancer. In total, 27.9% of the patients showed at least one deleterious variant in all 25 investigated genes and 26.4% in the defined 16 risk genes. Deleterious variants were most prevalent in the BRCA1 (15.5%), BRCA2 (5.5%), RAD51C (2.5%) and PALB2 (1.1%) genes. The prevalence of deleterious variants did not differ significantly between patients at primary diagnosis and relapse. The prevalence of deleterious variants in BRCA1/2 (and in all 16 risk genes) in patients <60 years was 30.2% (33.2%) versus 10.6% (18.9%) in patients \u226560 years. Family history was positive in 43% of all patients. Patients with a positive family history had a prevalence of deleterious variants of 31.6% (36.0%) versus 11.4% (17.6%) and histologic subtype of high grade serous ovarian cancer versus other showed a prevalence of deleterious variants of 23.2% (29.1%) and 10.2% (14.8%), respectively. Testing only for BRCA1/2 would miss in our series more than 5% of the patients with a deleterious variant in established risk genes."}, {"@Label": "CONCLUSIONS", "@NlmCategory": "CONCLUSIONS", "#text": "26.4% of all patients harbor at least one deleterious variant in established risk genes. The threshold of 10% mutation rate which is accepted for reimbursement by health care providers in Germany was observed in all subgroups analyzed and neither age at primary diagnosis nor histo-type or family history sufficiently enough could identify a subgroup not eligible for genetic counselling and testing. Genetic testing should therefore be offered to every patient with invasive epithelial ovarian cancer and limiting testing to BRCA1/2 seems to be not sufficient."}]}, "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "LastName": "Harter", "ForeName": "Philipp", "Initials": "P", "Identifier": {"@Source": "ORCID", "#text": "http://orcid.org/0000-0002-9663-5005"}, "AffiliationInfo": {"Affiliation": "Department of Gynecology & Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany."}}, {"@ValidYN": "Y", "LastName": "Hauke", "ForeName": "Jan", "Initials": "J", "AffiliationInfo": [{"Affiliation": "Center for Hereditary Breast and Ovarian Cancer, University Hospital Cologne, Medical Faculty, Cologne, Germany."}, {"Affiliation": "Center for Integrated Oncology (CIO), University Hospital Cologne, Medical Faculty, Cologne, Germany."}]}, {"@ValidYN": "Y", "LastName": "Heitz", "ForeName": "Florian", "Initials": "F", "AffiliationInfo": {"Affiliation": "Department of Gynecology & Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany."}}, {"@ValidYN": "Y", "LastName": "Reuss", "ForeName": "Alexander", "Initials": "A", "AffiliationInfo": {"Affiliation": "Coordinating Center for Clinical Trials, Philipps-University of Marburg, Marburg, Germany."}}, {"@ValidYN": "Y", "LastName": "Kommoss", "ForeName": "Stefan", "Initials": "S", "AffiliationInfo": {"Affiliation": "Department of Women's Health, T\u00fcbingen University Hospital, T\u00fcbingen, Germany."}}, {"@ValidYN": "Y", "LastName": "Marm\u00e9", "ForeName": "Frederik", "Initials": "F", "AffiliationInfo": {"Affiliation": "National Center for Tumor Disease/Department of Gynecology, University of Heidelberg, Heidelberg, Germany."}}, {"@ValidYN": "Y", "LastName": "Heimbach", "ForeName": "Andr\u00e9", "Initials": "A", "AffiliationInfo": {"Affiliation": "Institute of Human Genetics, University of Bonn, Bonn, Germany."}}, {"@ValidYN": "Y", "LastName": "Prieske", "ForeName": "Katharina", "Initials": "K", "AffiliationInfo": {"Affiliation": "Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany."}}, {"@ValidYN": "Y", "LastName": "Richters", "ForeName": "Lisa", "Initials": "L", "AffiliationInfo": [{"Affiliation": "Center for Hereditary Breast and Ovarian Cancer, University Hospital Cologne, Medical Faculty, Cologne, Germany."}, {"Affiliation": "Center for Integrated Oncology (CIO), University Hospital Cologne, Medical Faculty, Cologne, Germany."}]}, {"@ValidYN": "Y", "LastName": "Burges", "ForeName": "Alexander", "Initials": "A", "AffiliationInfo": {"Affiliation": "Department of Gynecology, University Hospital Munich-Gro\u00dfhadern. Munich, Germany."}}, {"@ValidYN": "Y", "LastName": "Neidhardt", "ForeName": "Guido", "Initials": "G", "AffiliationInfo": [{"Affiliation": "Center for Hereditary Breast and Ovarian Cancer, University Hospital Cologne, Medical Faculty, Cologne, Germany."}, {"Affiliation": "Center for Integrated Oncology (CIO), University Hospital Cologne, Medical Faculty, Cologne, Germany."}]}, {"@ValidYN": "Y", "LastName": "de Gregorio", "ForeName": "Nikolaus", "Initials": "N", "AffiliationInfo": {"Affiliation": "Department of Gynecology, University of Ulm, Ulm, Germany."}}, {"@ValidYN": "Y", "LastName": "El-Balat", "ForeName": "Ahmed", "Initials": "A", "AffiliationInfo": {"Affiliation": "Department of Gynecology, University of Frankfurt, Frankfurt, Germany."}}, {"@ValidYN": "Y", "LastName": "Hilpert", "ForeName": "Felix", "Initials": "F", "AffiliationInfo": [{"Affiliation": "Onkologisches Therapiezentrum, Krankenhaus Jerusalem, Hamburg, Germany/ Department of Gynecology, University of Kiel, Kiel, Germany."}, {"Affiliation": "Department of Gynecology, University of Kiel, Kiel, Germany."}]}, {"@ValidYN": "Y", "LastName": "Meier", "ForeName": "Werner", "Initials": "W", "AffiliationInfo": {"Affiliation": "Department of Gynecology, Evangelisches Krankenhaus, Duesseldorf, Germany."}}, {"@ValidYN": "Y", "LastName": "Kimmig", "ForeName": "Rainer", "Initials": "R", "AffiliationInfo": {"Affiliation": "Department of Gynecology, University of Essen, Essen, Germany."}}, {"@ValidYN": "Y", "LastName": "Kast", "ForeName": "Karin", "Initials": "K", "AffiliationInfo": [{"Affiliation": "Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden, Germany."}, {"Affiliation": "National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany."}, {"Affiliation": "German Cancer Consortium (DKTK), Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany."}]}, {"@ValidYN": "Y", "LastName": "Sehouli", "ForeName": "Jalid", "Initials": "J", "AffiliationInfo": {"Affiliation": "Department of Gynecology and Gynecological Oncology, Charit\u00e9, Campus Virchow, Berlin, Germany."}}, {"@ValidYN": "Y", "LastName": "Baumann", "ForeName": "Klaus", "Initials": "K", "AffiliationInfo": [{"Affiliation": "Department of Gynecology and Obstetrics, Klinikum Ludwigshafen, Ludwigshafen, Germany."}, {"Affiliation": "Department of Gynecology, Gynecologic Endocrinology & Oncology, Philipps-University Marburg, Marburg, Germany."}]}, {"@ValidYN": "Y", "LastName": "Jackisch", "ForeName": "Christian", "Initials": "C", "AffiliationInfo": {"Affiliation": "Department of Gynecology and Obstetrics, Sana Klinikum, Offenbach, Germany."}}, {"@ValidYN": "Y", "LastName": "Park-Simon", "ForeName": "Tjoung-Won", "Initials": "TW", "AffiliationInfo": {"Affiliation": "Department of Gynecology, Medizinische Hochschule Hannover, Hannover, Germany."}}, {"@ValidYN": "Y", "LastName": "Hanker", "ForeName": "Lars", "Initials": "L", "AffiliationInfo": {"Affiliation": "Department of Gynecology & Obstetrics, University Hospital Schleswig-Holstein, Campus L\u00fcbeck, L\u00fcbeck, Germany."}}, {"@ValidYN": "Y", "LastName": "Kr\u00f6ber", "ForeName": "Sandra", "Initials": "S", "AffiliationInfo": [{"Affiliation": "Center for Hereditary Breast and Ovarian Cancer, University Hospital Cologne, Medical Faculty, Cologne, Germany."}, {"Affiliation": "Center for Integrated Oncology (CIO), University Hospital Cologne, Medical Faculty, Cologne, Germany."}]}, {"@ValidYN": "Y", "LastName": "Pfisterer", "ForeName": "Jacobus", "Initials": "J", "AffiliationInfo": {"Affiliation": "Center of Gynecological Oncology, Kiel, Germany."}}, {"@ValidYN": "Y", "LastName": "Gevensleben", "ForeName": "Heidrun", "Initials": "H", "AffiliationInfo": {"Affiliation": "Institute of Pathology, University Hospital Bonn, Bonn, Germany."}}, {"@ValidYN": "Y", "LastName": "Schnelzer", "ForeName": "Andreas", "Initials": "A", "AffiliationInfo": {"Affiliation": "Department of Gynecology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany."}}, {"@ValidYN": "Y", "LastName": "Dietrich", "ForeName": "Dimo", "Initials": "D", "AffiliationInfo": {"Affiliation": "University Hospital Bonn, Department of Otolaryngology, Head and Neck Surgery, Bonn, Germany."}}, {"@ValidYN": "Y", "LastName": "Neunh\u00f6ffer", "ForeName": "Tanja", "Initials": "T", "AffiliationInfo": {"Affiliation": "Department of Gynecology, Dr. Horst-Schmidt-Kliniken, Wiesbaden, Germany."}}, {"@ValidYN": "Y", "LastName": "Krockenberger", "ForeName": "Mathias", "Initials": "M", "AffiliationInfo": {"Affiliation": "Department of Gynecology, University of W\u00fcrzburg, W\u00fcrzburg, Germany."}}, {"@ValidYN": "Y", "LastName": "Brucker", "ForeName": "Sara Y", "Initials": "SY", "AffiliationInfo": {"Affiliation": "Department of Women's Health, T\u00fcbingen University Hospital, T\u00fcbingen, Germany."}}, {"@ValidYN": "Y", "LastName": "N\u00fcrnberg", "ForeName": "Peter", "Initials": "P", "AffiliationInfo": [{"Affiliation": "Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany."}, {"Affiliation": "Cologne Center for Genomics (CCG), University of Cologne, Cologne, Germany."}, {"Affiliation": "Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany."}]}, {"@ValidYN": "Y", "LastName": "Thiele", "ForeName": "Holger", "Initials": "H", "AffiliationInfo": {"Affiliation": "Cologne Center for Genomics (CCG), University of Cologne, Cologne, Germany."}}, {"@ValidYN": "Y", "LastName": "Altm\u00fcller", "ForeName": "Janine", "Initials": "J", "AffiliationInfo": [{"Affiliation": "Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany."}, {"Affiliation": "Cologne Center for Genomics (CCG), University of Cologne, Cologne, Germany."}]}, {"@ValidYN": "Y", "LastName": "Lamla", "ForeName": "Josefin", "Initials": "J", "AffiliationInfo": {"Affiliation": "AGO Study Group, Wiesbaden, Germany."}}, {"@ValidYN": "Y", "LastName": "Elser", "ForeName": "Gabriele", "Initials": "G", "AffiliationInfo": {"Affiliation": "AGO Study Group, Wiesbaden, Germany."}}, {"@ValidYN": "Y", "LastName": "du Bois", "ForeName": "Andreas", "Initials": "A", "AffiliationInfo": {"Affiliation": "Department of Gynecology & Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany."}}, {"@ValidYN": "Y", "LastName": "Hahnen", "ForeName": "Eric", "Initials": "E", "AffiliationInfo": [{"Affiliation": "Center for Hereditary Breast and Ovarian Cancer, University Hospital Cologne, Medical Faculty, Cologne, Germany."}, {"Affiliation": "Center for Integrated Oncology (CIO), University Hospital Cologne, Medical Faculty, Cologne, Germany."}]}, {"@ValidYN": "Y", "LastName": "Schmutzler", "ForeName": "Rita", "Initials": "R", "AffiliationInfo": [{"Affiliation": "Center for Hereditary Breast and Ovarian Cancer, University Hospital Cologne, Medical Faculty, Cologne, Germany."}, {"Affiliation": "Center for Integrated Oncology (CIO), University Hospital Cologne, Medical Faculty, Cologne, Germany."}]}]}, "Language": "eng", "PublicationTypeList": {"PublicationType": {"@UI": "D016428", "#text": "Journal Article"}}, "ArticleDate": {"@DateType": "Electronic", "Year": "2017", "Month": "10", "Day": "20"}}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "PLoS One", "NlmUniqueID": "101285081", "ISSNLinking": "1932-6203"}, "CitationSubset": "IM", "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"@UI": "D005260", "@MajorTopicYN": "N", "#text": "Female"}}, {"DescriptorName": {"@UI": "D019398", "@MajorTopicYN": "Y", "#text": "Genes, BRCA1"}}, {"DescriptorName": {"@UI": "D024522", "@MajorTopicYN": "Y", "#text": "Genes, BRCA2"}}, {"DescriptorName": {"@UI": "D020022", "@MajorTopicYN": "Y", "#text": "Genetic Predisposition to Disease"}}, {"DescriptorName": {"@UI": "D018095", "@MajorTopicYN": "Y", "#text": "Germ-Line Mutation"}}, {"DescriptorName": {"@UI": "D006801", "@MajorTopicYN": "N", "#text": "Humans"}}, {"DescriptorName": {"@UI": "D010051", "@MajorTopicYN": "N", "#text": "Ovarian Neoplasms"}, "QualifierName": {"@UI": "Q000235", "@MajorTopicYN": "Y", "#text": "genetics"}}]}}, "PubmedData": {"History": {"PubMedPubDate": [{"@PubStatus": "received", "Year": "2017", "Month": "06", "Day": "09"}, {"@PubStatus": "accepted", "Year": "2017", "Month": "09", "Day": "22"}, {"@PubStatus": "entrez", "Year": "2017", "Month": "10", "Day": "21", "Hour": "6", "Minute": "0"}, {"@PubStatus": "pubmed", "Year": "2017", "Month": "10", "Day": "21", "Hour": "6", "Minute": "0"}, {"@PubStatus": "medline", "Year": "2017", "Month": "11", "Day": "29", "Hour": "6", "Minute": "0"}]}, "PublicationStatus": "epublish", "ArticleIdList": {"ArticleId": [{"@IdType": "pubmed", "#text": "29053726"}, {"@IdType": "doi", "#text": "10.1371/journal.pone.0186043"}, {"@IdType": "pii", "#text": "PONE-D-17-20603"}, {"@IdType": "pmc", "#text": "PMC5650145"}]}, "ReferenceList": {"Reference": [{"Citation": "J Clin Oncol. 2012 Jul 20;30(21):2654-63", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "22711857"}}}, {"Citation": "Eur J Cancer. 2004 Feb;40(3):422-8", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "14746861"}}}, {"Citation": "Nat Genet. 2010 May;42(5):410-4", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "20400964"}}}, {"Citation": "BMC Cancer. 2016 Dec 3;16(1):934", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "27914478"}}}, {"Citation": "Clin Cancer Res. 2008 Jun 15;14(12):3761-7", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "18559594"}}}, {"Citation": "J Natl Cancer Inst. 2013 Jun 5;105(11):812-22", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "23628597"}}}, {"Citation": "N Engl J Med. 1997 Apr 17;336(16):1125-30", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "9099656"}}}, {"Citation": "JAMA Oncol. 2016 Apr;2(4):482-90", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "26720728"}}}, {"Citation": "N Engl J Med. 2015 Jun 4;372(23):2243-57", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "26014596"}}}, {"Citation": "Adv Ther. 2016 Feb;33(2):129-50", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "26809252"}}}, {"Citation": "Gynecol Oncol. 2011 Jun 1;121(3):615-9", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "21414656"}}}, {"Citation": "Hum Mutat. 2008 Nov;29(11):1282-91", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "18951446"}}}, {"Citation": "Adv Ther. 2012 Sep;29(9):723-35", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "22941523"}}}, {"Citation": "Am J Pathol. 2004 May;164(5):1511-8", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "15111296"}}}, {"Citation": "Ann Oncol. 2012 Oct;23(10):2605-12", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "22910840"}}}, {"Citation": "Gynecol Oncol. 2016 Mar;140(3):443-9", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "26740259"}}}, {"Citation": "Br J Cancer. 2016 Oct 11;115(8):993-999", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "27632374"}}}, {"Citation": "Cancer Discov. 2015 Nov;5(11):1137-54", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "26463832"}}}, {"Citation": "Proc Natl Acad Sci U S A. 2011 Nov 1;108(44):18032-7", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "22006311"}}}, {"Citation": "Int J Gynecol Cancer. 2017 Mar;27(3):444-451", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "28187099"}}}, {"Citation": "JAMA. 2011 Jun 8;305(22):2295-303", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "21642681"}}}, {"Citation": "Gynecol Oncol. 2015 May;137(2):343-50", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25725131"}}}, {"Citation": "Ann Surg Oncol. 2006 Dec;13(12):1702-10", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "17009163"}}}, {"Citation": "Clin Cancer Res. 2014 Feb 1;20(3):764-75", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "24240112"}}}, {"Citation": "Science. 2003 Oct 24;302(5645):643-6", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "14576434"}}}, {"Citation": "Am J Hum Genet. 2001 Mar;68(3):700-10", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "11179017"}}}, {"Citation": "Eur J Health Econ. 2017 Apr 5;:null", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "28382503"}}}, {"Citation": "Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):15172-7", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25288723"}}}, {"Citation": "J Natl Cancer Inst. 2015 Aug 27;107(11):", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "26315354"}}}, {"Citation": "CA Cancer J Clin. 2016 Jul;66(4):271-89", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "27253694"}}}, {"Citation": "Br J Cancer. 2008 Apr 22;98(8):1457-66", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "18349832"}}}, {"Citation": "J Natl Cancer Inst. 2003 Sep 3;95(17):1320-9", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "12953086"}}}, {"Citation": "Eur J Cancer. 2015 Oct;51(15):2191-2205", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "26421822"}}}, {"Citation": "Am J Hum Genet. 2003 May;72(5):1117-30", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "12677558"}}}]}}}]}}